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Background:  Multiple internal and external factors are responsible for the development 
and progression of chronic obstructive pulmonary disease (COPD). Noxious stimuli such 
as cigarette smoking and other air borne pollutants set off the ongoing inflammatory 
process of COPD resulting in air flow limitation and lung tissue destruction. 
Objectives: Examination of inflammatory mediators of COPD and risk factors that 
coincide with hospital admission for AECOPD. The aim of this dissertation was to 
conduct a feasibility study to implement an educational intervention for hospitalized 
patients and evaluate their quality of life (QOL), using the RE-AIM framework to 
evaluate outcomes. 
Design:  This dissertation includes three papers: a principle-based concept analysis on 
inflammatory mediators related to COPD, an integrative review of the psychometric 
instruments used to measure risk factors for hospitalization among patients with COPD, 
and a feasibility study using the American Lung Association’s modified COPD Action 
Plan to instruct patients with COPD on identifying early signs of an exacerbation and 
when to seek medical care. In addition, quality of life perceptions were evaluated using 
the World Health Organization-BREF (WHOQOL-BREF) before hospital discharge and 
30 days post discharge via phone call. 
Conclusions: COPD is a complex chronic disease with an insidious onset by 
inflammatory mediator(s) or genetic origin. The episodic acute exacerbations of COPD 
(AECOPD) are responsible for high healthcare utilization and perceptions of low quality 
of life. The feasibility study results suggest implementation of the American Lung 
Association modified COPD Action Plan can be carried out as discharge instructions and 
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QOL evaluated using the WHOQOL-BREF questionnaire.  Positive ratings and 
comments on the delivery and content of the COPD Action Plan were found in a small 




Chronic obstructive pulmonary disease (COPD) is one of the most common 
chronic diseases in the United States (US) with approximately 13.6 million individuals 
diagnosed with COPD and an equal number undiagnosed (Healthy People 2020, 2012).  
The physical, psychological and economic burden of living with COPD negatively affects 
quality of life (QOL) of patients and their caregivers. COPD is the third leading cause of 
death in the US, and management of the disease remains suboptimal (National Institutes 
of Health, 2013). 
Due to complex ongoing inflammation, COPD is a progressively deteriorating 
lung disease. Ongoing exposure to noxious sources of inhalational irritants from cigarette 
smoking, occupational exposures, and outdoor air pollution perpetuate an inflammatory 
cascade and ultimately lead to airway airflow limitation (Barnes, 2016).  COPD is an 
insidious respiratory disease due to chronic and acute episodes of inflammation. 
Acute exacerbation of COPD (AECOPD) is defined as acute flares of 
inflammation that frequently lead to hospitalization for patients with COPD.  Risk factors 
involving hospitalization for patients with COPD include: comorbidities, past 
hospitalizations, low forced expiratory volume in one second (FEV1), socioeconomic 
status (urban and rural), physical functional ability (ambulating, bathing and dressing), 
psychological aspects of anxiety, and depression impacting QOL (American College of 
Chest Physicians, 2012; Conley & Gregoski, 2015).  AECOPD is the third most common 
cause of hospital readmissions within 30 days post discharge. The incidence of 
recidivism is likely to occur in patients with comorbidities or those with more serious 
COPD disease (Panettieri, 2013). 
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For both patients and the health care system, there is tremendous financial 
responsibility, with an estimated $50 billion spent annually in consumption of health care 
resources and other costs due to work absences (American College of Chest Physicians, 
2014; Jalota & Jain, 2016; Jennings et al., 2014;).  Complicating matters, approximately 
20% of individuals discharged from US hospitals are readmitted within 30 days (Centers 
of Medicare and Medicaid, 2014), and Centers of Medicare and Medicaid (CMS) 
withhold compensation to hospitals for these readmissions, costing an average of 
$130,000 to each US hospital. A more effective chronic care management process is 
critically needed by the US acute care system (Centers of Medicare and Medicaid, 2014; 
Polster, 2015). 
This dissertation is composed of three papers that link the complex etiology of 
inflammation in COPD to the risk factors among individuals hospitalized with COPD and 
the need for an educational intervention.  Potentially, an educational intervention could 
reduce morbidity and mortality and improve perceived QOL.  The first paper is a 
principle-based concept analysis that examines inflammatory mediators involved in 
triggering the onset and chronic progression of inflammation in COPD.  The paper 
highlights the risks of being exposed to external factors (indoor, outdoor pollution, and 
smoking) and internal factors (aspects related to the inflammatory process and genetics) 
responsible for COPD exacerbations (Barnes, 2016).  This concept analysis of what 
causes inflammation in COPD by inflammatory mediators is a stepping stone to 
understanding the acute exacerbations of COPD (AECOPD).  The paper has been 
accepted for publication. 
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The second paper, which has been published, is an integrative review of the risk 
factors associated with hospital admission related to COPD and highlighted the need to 
assess patients with COPD for the risk of readmission (Conley & Gregoski, 2015).  
Examining the best methods to measure risk factors for developing COPD complications 
leading to hospital readmission, as well as assessing for QOL perceptions of patients 
hospitalized with COPD, is essential to improving care and QOL for these patients.  
Therefore, it was determined that a concise instrument is needed to assess risk factors for 
hospital admission of patients with COPD (Conley & Gregoski, 2015; Kansagara et al., 
2011). 
The concept analysis of inflammatory mediators and integrative review of risk 
factors for hospitalization among patients with COPD served as groundwork for the 
dissertation study.   Consequently, the third paper is from the dissertation study, which 
investigated an education model prior to discharge.  The goal of this study was to educate 
hospitalized patients with COPD to recognize early changes in their condition.  
Accordingly, learning to identify changes at the onset, most times, signals the need to 
contact a medical provider or to seek more advanced medical care in order to prevent 
further morbidity and mortality of recurrent COPD acute exacerbations.  The study 
evaluated the feasibility of implementing the American Lung Association (ALA) COPD 
Action Plan to provide an individualized, disease specific discharge education to patients 
with COPD and evaluate QOL using the World Health Organization-BREF (WHOQOL-
BREF) (ALA, 2013; WHOQOL-BREF, 1997).  Distinctly, the goal was to increase 
patients’ knowledge of changes in respiratory symptoms and related effects of COPD and 
of when to seek prompt medical care.  Such knowledge may decrease occurrences of 
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AECOPD and hospital admissions of patients with COPD, as well as improve QOL 
perceptions by participants (Choi, Chung, & Han, 2014; Mitchell et al., 2016). 
A structured action plan, delivered individually, may help overcome obstacles to 
teaching patients with COPD, many of which are related to the diverse needs and 
backgrounds of patients, making it essential to deliver discharge instructions one-to-one, 
nurse to patient (Hanania, 2012; Sheppard et al., 2013, Polster, 2015).  Also, it is 
common for patients with COPD to experience anxiety and depression related to 
breathlessness episodes and decreased functional abilities that impair perceptions of QOL 
(Coventry, Gemmell & Todd, 2011; Ries, 2006). As a result, the modified COPD Action 
Plan was selected because it is a concise format for educating patients on self-
management and symptom control, and because it has an easy-to-understand format.  The 
instructions are organized in color zones to illustrate how patients should self-assess how 
they feel, ranging from good day (green), bad day (yellow), and when there is an urgent 
need for medical care (red).  Thus, the plan highlights the need to promptly act on 
changes in symptoms that signal the need to contact or seek professional health care 
(American Lung Association, 2013; Effing et al., 2012).  Additionally, this plan is 
familiar to pulmonary medical providers due to the widespread use of these types of 
asthma action plans.  Next, QOL before and after discharge from the hospital was 
measured with the WHOQOL-BREF. The WHOQOL-BREF was selected because it is a 
reliable and validated instrument with 26-items measuring physical, psychological, 
social, and environmental domains (Skevington, Lofty & O’Connell, 2004). 
To measure feasibility of this discharge clinical procedure, the Reach, 
Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework was 
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used to evaluate delivery of the action plan as a discharge teaching tool via the 30 day 
follow up phone call after discharge (Glasgow, Vogt & Boles, 1999).  Reach included 
recruitment and retention of the sample population of participants with COPD 
hospitalized on a Progressive Care Unit (PCU).  Effectiveness was measured by outcome 
of the participants’ perception of benefit of the COPD Action Plan based on a 30 day 
follow up survey and qualitative results. PCU nurse completion of a questionnaire on 
perception of benefit involving the discharge intervention to participants with COPD was 
evaluated.  The survey completed by a PCU nurse was used to evaluate acceptance and 
feasibility by the PCU nurse trained to instruct participants on the COPD Action Plan.  
Adoption was evaluated by PCU nursing staff (rated responses) and participants’ 
perception of willingness to adopt the discharge clinical procedure (rated responses, 30 
day outcomes of health care utilization and QOL outcomes).  Implementation of the 
clinical procedure was appraised by consistency in delivery (fidelity) of the COPD 
discharge procedure assessed by observation and based on feedback from participants 
and the nurse’s recommendations.  Maintenance of the discharge procedure for patients 
with COPD (survey and qualitative results) to be used hospital-wide will be determined 
following completion of this study (Carnerio et al., 2010; Glasgow, Vogt & Boles, 1999). 
Overall, the long term objective of this dissertation study was to, first, provide a 
specific strategy to address the educational needs of patients with COPD in the acute care 
setting and, second, identify issues of participants that are associated with their QOL 
(National Institute of Nursing Research, 2013; Scott, Baltzan, Dajczman, & Wolkove, 
2011).  Evidence suggests that reducing dyspnea or improving ways to cope with 
breathlessness, such as learning pursed lip breathing, improves QOL (Feldman, 2013).  
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Additionally, support networks by phone or online help patients cope with anxiety and 
depression.  Future studies should address ways to teach patients to conserve their energy 
that could potentially improve perceived QOL related to impaired activity tolerance from 
dyspnea. 
Research Question 
What is the outcome of using the American Lung Association COPD Action Plan 
in terms of self-rated knowledge and assessment of QOL in a cohort of patients 
discharged from a Progressive Care Unit after hospitalization for an AECOPD or COPD? 
Gaps in Knowledge 
Based on a review of the literature, research evidence is limited regarding 
outcomes of specific patient education instruments delivered during hospitalization and 
evaluating QOL (Almago & Castro, 2013; Mularski et al., 2012).  Compared to COPD 
action plans, action plans for asthma have been studied more extensively for their 
educational impact on respiratory symptoms and self-management outcomes. Jalota and 
Jain (2016) report that 400 asthma action plans have been investigated as to their 
effectiveness in teaching self-management of symptoms compared to 69 studies on 
COPD action plans.  Their findings on asthma action plans indicated effectiveness in 
prevention of more severe asthma exacerbations. COPD action plans may be beneficial to 
patients in acquiring knowledge, increasing confidence in managing their lung disease, 
and making decisions when to contact health care providers. 
Few studies have evaluated the most effective evidence-based action plans that 
teach specific self-management to guide discharge education for hospitalized patients 
with COPD.  Further evidence is needed on outcomes of improved self-management, 
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such as through early recognition of symptoms, prompt medical care, reduced hospital 
readmissions, and improved perceived QOL post discharge (Bischoff et al., 2011; Effing 
et al., 2012; Jennings et al., 2014).  Sunde et al. (2014) implemented a prospective 
clinical intervention study using a multidisciplinary COPD-Home model to teach 
individualized self-management skills and provide support from other health care 
professionals.  Also, Sunde et al. (2014) described the outcome strengths of the model 
being integrated care and continuous reinforcement of self-management skills to improve 
COPD.  Sunde and colleagues pointed out that evidence is needed to support 
effectiveness and impact on QOL (Sunde et al., 2014). Moreover, given obstacles to 
teaching patients with COPD, many of which are related to the diverse needs and 
backgrounds of patients, it is essential to deliver individually tailored discharge 
instructions (Hanania, 2012; Polster, 2015; Sheppard et al., 2013). 
Using a COPD self-management education plan for outpatients in a prospective 
study, using a parallel group, by Labrecque et al. (2011) found a decrease in emergency 
department (ED) visits measuring participants per year (p = 0.002).  In addition, 
hospitalizations were reduced (p = 0.17). Researchers attributed the nonsignificant result 
to the specific definition of ED visits being 24 hours or less, and improved health-related 
quality of life (HRQOL) in patients with COPD at 12 months (p < 0.001).  Scott and 
colleagues (2011) compared knowledge of COPD and information needs of outpatients 
and in hospital patients with COPD using two questionnaires.  Reported results showed a 
positive correlation between prior COPD learning and high school education (p < 0.05).  
Also, a positive correlation was found from prior COPD instructions and lower Lung 
Information Needs Questionnaire (LINQ) score (p < 0.01) (Scott et al., 2011).  
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Researchers Choi, Chung, and Han (2014) conducted a cross-sectional descriptive study 
on outpatients in a COPD clinic and found adherence to an action plan reduced 
unplanned hospitalizations (p = 0.001). 
Trappenburg et al. (2011) conducted a multicenter randomized controlled trial on 
outpatients, to test the effectiveness of administering personalized COPD action plans to 
reduce exacerbation recovery time and every three days completed the Clinical COPD 
Questionnaire (CCQ) to measure health status. Their results based on the CCQ scores 
indicated above the minimal pertinent difference 0.4 points (p </ 0.01) (Trappenburg et 
al., 2011).  Other researchers carried out a randomized controlled trial to assess the 
impact of a comprehensive intervention for patients with COPD discharged from the 
hospital (Ko et al., 2016).  What the researchers found, based on the intervention group, 
was a reduction in hospitalization for AECOPD (p = 0.047) and decreased length of stay 
(LOS) (p </ 0.001) (Ko et al., 2016).  Ko et al. (2016) were not able to provide evidence 
as to what particular intervention was most effective. 
Furthermore, Krishnan and researchers found that multidisciplinary educational 
action programs, not disease specific, included evaluation of QOL, physical exercise, and 
follow up phones calls to patients after discharge, decreased hospitalizations (Krishnan et 
al., 2015; Nelson & Pulley, 2015).  In addition, findings were investigated from 
comprehensive discharge programs that bundle interventions (education, exercise, and 
follow up phone calls after discharge) such as Project Better Outcomes through 
Optimizing Safe Transitions (BOOST) for COPD patients.  Results showed improved 
outcomes, fewer hospitalizations, and increased QOL.  Mularski et al. (2012) examined 
comparative effectiveness research for patients with COPD. They called for collaboration 
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among researchers, clinicians, payers, and policymakers in broadening methodologies 
such as repeating performed effectiveness designs that examine longitudinally over time 
positive and negative outcomes, as well as expense (Mularski et al., 2012). 
In summary, the findings point to a need for conformity of a statistically proven 
effective COPD discharge instructions delivered (either written, audiovisual, or electronic 
tablet-based) to improve self-management among patients with COPD (Choi et al., 2014, 
Mularski et al., 2012; Sawyer et al., 2016; Schafer et al., 2015).  Future studies are 
needed that detail implementation, content of instructions, and are individualized based 
on assessment of prior participant knowledge of self-management and evaluation of 
QOL. (Effing et al., 2012). 
Design and Method 
The study took place on a 24-bed Progressive Care Unit (PCU) at an urban 
hospital.  Descriptive statistics will report the demographic data and participant 
characteristics.  The Wilcoxon signed-ranks test will be used to compare QOL domain 
scores of participants before hospital discharge and again from the 30 phone call 
reevaluation of QOL.  Qualitative data was obtained from the participants during the 30 
day call back which was pulled out from open ended comments.  These comments were 
read and reviewed with my qualitative mentor and the prevailing themes were 
categorized. 
Theoretical Framework 
Socio-Ecological Model (SEM) was used to guide the paper involving risk factors 
for hospitalization of patients with COPD and development of the structured discharge 
educational protocol and QOL evaluation.  Application of SEM for the feasibility study 
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was appropriate because it recognizes the interconnectedness in layers of influence for 
patients with COPD (Centers for Disease Control and Prevention, 2015).  The framework 
consists of multiple levels of influence which include: the individual, their knowledge, 
motivation and skills; interpersonal relationships that consists of, family, friends and 
social network; organizations, involving environmental factors such as air pollutants 
indoors and outdoors, smoking first hand or second hand.  In addition to community 
resources composed of connections and support between organizations in the community, 
and home.  Public policies embody the laws to support and protect individuals and 
communities (CDC, 2015). The SEM provided a relevant framework to create an 
educational solution to instruct critically ill hospitalized patients with COPD on self-
management skills to identify and manage respiratory symptoms as well as to evaluate 
their perceptions of QOL. 
Conclusion 
This dissertation explored the concept of inflammation using a principle-based 
concept analysis to examine inflammatory mediators related to the onset of chronic and 
acute inflammation in COPD.  The concept analysis of recent findings involving 
inflammatory mediators revealed that further investigation is needed, in order to clearly 
define the triggers to inflammation.  Furthermore, research is essential to discover what 
preventive measures or pharmacological antagonists to inactivate the triggers involving 
inflammation in COPD. 
The second paper describes the psychometric measurements that have been used 
to determine how best to identify and predict patients with COPD who are most at risk 
for AECOPD that results in hospitalization and rehospitalization, especially within 30 
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days following discharge for the same.  Clearly, this integrative review illustrated how 
many studies used several instruments to assess risk factors for hospitalization among 
patients with COPD.  Rational for using numerous measurements to determine risk 
factors for hospital admission was attributed to the multifactorial entity of COPD that 
includes severity of disease, psychosocial, and socioeconomic factors of each individual.  
Producing a valid and concise instrument to pin-point at risk patients with COPD for 
hospital admission in the critical care setting would be valuable.  
        Culmination of the principle-based concept analysis paper on inflammatory 
mediators in COPD and integrative review of risk factors for hospitalization for 
AECOPD among patients with COPD was the premise for the structured discharge 
feasibility study. This study was designed and conducted to examine delivery of the 
modified ALA COPD Action Plan, assess QOL using the WHOQOL-BREF, and 
evaluate outcomes using the RE-AIM Framework.  Recruitment of the goal sample 
population was met, but possible barriers to retention of participants in the 30 day follow 
up that was low, which could be attributed to lack of compliance and socioeconomic 
barriers.  Adoption was evaluated by the participant and one trained PCU nurse 
responses, which was limited due to the small follow-up sample (n =13)..  The 
participants, who were reached via phone call on the 30 day follow-up, reported low 
healthcare utilization which may indicate gained knowledge of taking their prescribed 
respiratory medication and keeping scheduled appointments after hospital discharge.  
There was no difference in scores taken in hospital and 30 day follow-up by phone using 
the WHOQOL-BREF, calculated with the Wilcoxon signed-ranks test.  The WHOQOL-
BREF has documented reliability and validity, but for this critically ill patient population, 
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it was imperative for the PI to read and record the answers for the participants.  
Implementation in the delivery of the COPD Action Plan to participants was feasible 
based on the response from the PCU nurse and the PI.   Taking the strengths from the 
outcomes of this feasibility study, the PCU clinical manager approved use of the 
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Aim: To report a principle-based concept analysis of inflammatory mediators related to 
chronic obstructive pulmonary disease (COPD). 
Background: In patients with COPD, acute and chronic inflammation within the 
bronchi cause luminal narrowing from mucosal edema, smooth muscle contraction and 
mucus production that contributes to gas exchange impairment. Shortness of breath and 
limited exercise tolerance are common symptoms of COPD.  The mediators that trigger 
acute inflammatory responses and perpetuate chronic inflammation in COPD have been 
investigated on a molecular, cellular, and global physiologic level. The exact mediators 
of inflammation have not been conclusively determined.   
Design: Principle-based method of concept analysis. 
Methods: Systematic review of the literature in 2015 using the MeSh words 
“pulmonary disease, chronic obstructive” AND MeSh words “inflammation mediators” 
in only English were searched in PubMed, CINAHL, Cochrane, Medline and Google 
Scholar. 
Results: The concept of inflammation continues to evolve.  There are now numerous 
inflammatory mediators linked to COPD. Four principles are used to conduct the 
concept analysis of inflammation in COPD: linguistic, logical, epistemological, and 
pragmatic. The final analysis retained 15 articles. 
Conclusions: This paper provides insight regarding the concept of inflammation within 
COPD by developing epistemology on the exact factor(s) triggering inflammation. The 
global impact of this debilitating disease and high level of health care utilization calls 
for a collaboration among health care providers and researchers. 
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Relevance: Nursing has a pivotal role in caring for patients with COPD and conducting 
research on mediators of inflammation related to COPD. Further research is needed to 
discover definitively mediators that perpetuate of this serious lung disease in order to 
improve outcomes. Such outcomes would identify the prevention strategies and develop 
treatments that could better target the detrimental effects of this inflammation. 
Keywords: COPD lung inflammation, pulmonary disease, chronic obstructive and 





Inflammation has a historical and scientific background related to lung 
inflammation which can best be understood using the lens of the principle-based 
concept analysis.  A documented history identifies and describes inflammation dating as 
far back as 2000 years ago.  Medzhitov, a professor of immunology, defined 
inflammation as a process triggered by tissue injury or infection, which elicits the 
recruitment of plasma proteins and leukocytes to the affected site.1 Having knowledge 
of the phenomenon involving inflammation for nurses is necessary due to the impact on 
many aspects of providing care (teaching patients avoidance of precipitating factors), 
education (instructing patients on prescribed anti-inflammatory medications), and 
research (for evidence-based practice). Therefore, evidence-based knowledge, regarding 
causes related to the altered inflammatory process involving COPD that results in air 
flow limitation, is essential for health care professionals.2 Understanding the science 
identifying the triggers of mechanisms causing inflammation associated with COPD can 
be translated to the importance of avoiding pollutants. Sources of pollutants can 
include: being a smoker or exposure to second hand cigarette smoke, occupational, 
indoor, or outdoor sources.  Other sources encompass being in close proximity to 
industrial or high traffic areas, or during times there are high ozone alerts. 1-3 
The principle-based concept analysis is a blueprint to build on the clinical 
understanding of inflammation for the underpinning of professional nursing practice 
and other health care professionals. Penrod and Hupcey’s four principles: 
epistemological, pragmatic, linguistic, and logical will be used to assess the level of 
maturity for the concept of inflammation.6 While inflammation is on one hand 
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beneficial, as in the process of wound healing, it can be detrimental when it causes 
swelling in bronchial tubes making breathing and air exchange difficult.7 Over time, 
chronic inflammation leads to destruction in the lung tissue results in COPD. In health 
care, timely and accurate identification of an acute exacerbation of COPD (AECOPD) 
involving an acute inflammatory response is critical. AECOPD occurrences causes 
more frequent coughing with many times increased production of sputum, worsening 
activity tolerance related to difficulty breathing, and further dyspnea (breathlessness) 
could ultimately result in respiratory failure (Global Initiative for Chronic Obstructive 
Pulmonary Disease (GOLD).8  The seriousness of COPD is documented by the National 
Institutes of Health as being the third leading cause of death in the United States and the 
fourth leading cause of death globally.7, 9-11 
Background 
Inflammation has been poignantly referred to as the old flame, but without the 
actual fire. This means that inflammation can cause similar pain and discomfort as a burn, 
but not be caused by an actual burn from a fire.  The term ‘edema’ carries over to today 
as being part of a common descriptive involving inflammation that began with 
Hippocrates in the 5th century BC, in which he described edema being part of the healing 
process following tissue injury.12  During the 1st century, Celsus, a Roman encyclopedist, 
defined the four signs of inflammation with the terms: “rubor, et tumor cum calore et 
dolore” meaning redness and swelling with heat and pain (p. 958).13  A fifth component 
was added by a Greek physician Galen, to the signs of inflammation, “function laesa” 
that described  impaired function of an affected extremity (p. 104).14  Elie Mechnikoff, a 
zoologist, discovered the outcome in “leukocyte recruitment and phagocytosis of 
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microorganisms involving human protection against inflammation, infection, and 
immunity” (p. 3257).15 This finding propelled the understanding of inflammatory process 
for treatment.1,15  Scott et al. pointed out that the definition of inflammation has 
dramatically changed since the origin of its use almost 2000 years ago.16  Currently, the 
meaning of inflammation is determined by how it is assessed “clinically, microscopically 
at the cellular or molecular level” (p.248).16 
Inflammation related to COPD is manifested in several forms. The onset of 
COPD is most commonly a progressive form that is insidious and continuous, as 
compared to the critical manifestation that occurs in acute exacerbations of COPD 
(AECOPD). The first form of inflammation contributes to the ongoing downward spiral 
of worsening restrictive air flow condition in the lungs. In the acute form, the impact to 
the pulmonary system is so severe that most patients do not fully recover. The concept of 
inflammation is knowingly linked to physiological mediators responsible for COPD, but 
they are still not completely understood. There is heterogeneity in the scientific evidence 
for mediators as the culprit for the abnormal inflammatory pathophysiology in COPD.17 
Data sources 
A review of the literature was performed to carry out the principle-based concept 
analysis of inflammation which produced information on the scientific findings 
pertaining to mediators for inflammation in patients with COPD.  Multiple data base 
search engines were used to obtain articles related to inflammatory mediators in COPD. 
PubMed, CINAHL, Google Scholar, Cochrane via EBSCO interface, and Medline via 
EBSCO interface was searched using the following MeSH terms: “pulmonary disease, 
chronic obstructive” AND MeSH terms “Inflammation-Mediators.”  Inclusion criteria 
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and results from each data base: adults, adults with COPD, mouse models examining 
causes of inflammation related to COPD.  Exclusion criteria included pediatric studies 
and those delivering treatments or interventions for lung inflammation. 
 A systematic review was conducted to obtain studies for use in the principle-
based concept analysis which included 15 articles in the final data set. Abstracts were 
reviewed and study types ranged from those having adult humans and mouse models. 
Antecedents 
 A concept analysis of inflammation requires an understanding involving the 
antecedents of inflammation.  Antecedents of inflammation in COPD involve a precursor 
or stimulus from which an individual is exposed to such as cigarette smoke first hand, 
second hand, or some type of air pollution. The stimulus in most cases is the trigger for 
mediators that set into motion the detrimental inflammatory activity, described by the 
Latin term “inflammare (to set on fire)” the Latin term.16 
Attributes 
 The characteristic attributes of inflammation include: redness, warmth, 
swelling, pain, and limited function.18 For COPD, chronic inflammation is 
attributable to breathlessness especially on exertion and poor activity tolerance.  In 
an AECOPD, an individual can exhibit some of the following clinical signs and 
symptoms of increased difficulty breathing (dyspnea) or breathlessness, increased 
frequency of cough, productive cough with colored sputum (yellow, green or 
sometimes blood tinged).7 Moreover, building on the historical roots of 
inflammation, its antecedents as well as the attributes, we gain an understanding 
when conducting an assessment of a patient’s respiratory function. Classification of 
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airflow limitation in COPD individuals is measured by spirometry that calculates 
the volume of air an individual can exhale from their lungs following a maximum 
inspiration.8  The Global Initiative for COPD established the measurement of 
forced expiratory volume in one second (FEV1) being less than 70% as a marker of 
COPD.8 Table 1. 
Linguistic principle 
 To fulfill the linguistic principle, a concept needs to have consistency in its use 
and meaning.6 Therefore, from the analysis of the linguistic principle the meaning of 
inflammation found in COPD is used consistently throughout the literature, in that it 
results in air flow limitation.19  Scientific evidence is not uniform surrounding the 
physiological process of mediators attributable to the dysfunctional inflammatory process 
in COPD. Irregularity exists in the evidence on mediators of how they cause acute 
exacerbations of COPD and the chronic progression of the disease, is still being 
investigated. Table 2. The literature reflects how empirical measurements have evolved 
in an effort to establish uniformity in quantifying the symptoms that are a consequence of 
inflammation. Calculating the degree of severity involving airflow limitation, as 
described by GOLD, is an indirect quantitative measurement that reflects the effects of 
inflammation.  GOLD employs a classification of COPD severity ranging from mild to 
severe. Mild COPD is classified as forced expiratory volume in one second (FEV1) 
“post-bronchodilator use >/ 80% predicted to severe FEV1 <30% predicted” (p. 9).8 
 Use of a standardized instrument that has a scale with clinical descriptions to 
quantify clinical features of patients having respiratory difficulty would promote 
distinctions in severity of respiratory distress.  Such a standardized instrument to assess a 
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patient in the acute and critical care setting would be valuable.  Being able to rate the 
severity of dyspnea could add to the objectivity of a respiratory assessment of patients 
with COPD, especially for patients who are unable to describe their symptoms due to 
altered cognition or effects of hypoxia or hypercapnia.20  
Logical principle 
 A concept is logical if it maintains its framework within the limits of theory 
application.6  Sources in the literature cited external inflammatory factors from cigarette 
smoking to ozone levels.  What the literature confirmed to be uncertain was that various 
precipitating pathophysiological sources elicit a variety of identified mediators. Some 
mechanisms identified to be accountable for inflammation in COPD include the alteration 
in Sirtuin1 Protein Coding gene in the circadian molecular clock rhythm of cigarette 
smokers.21  Other researchers found proteases in agricultural dust from enclosed animal 
feeding sites and household mite dust to be mediators.4  Consistently, the literature cited 
external inflammatory factors being predominately cigarette smoking as the most 
common noxious stimuli eliciting cellular and molecular mechanisms responsible for 
inflammation found in COPD.22-24  Barouchos et al found tumor markers were related to 
inflammation of COPD and the degree of disease severity.25  Haw and colleagues 
reported from their research an increase in tumor necrosis factor-related cell self-
destruction (apoptosis) induced ligand (TRIAL), a cytokine to be the key in the abnormal 
inflammatory pathology in COPD.26  Other researchers found exposure to cigarette 
smoking resulted in an abnormal reaction of causing an increase in Tc17 cells which 
scientists related to inflammation related to COPD.27 
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 Another study identified pathogenic microorganisms in sputum to be linked to 
inflammation in COPD.5, 28  Increased levels of pigment epithelium-derived factor 
(PEDF) correlated with inflammation involved in COPD and decreased FEV1.29  Other 
studies revealed the amount of progranulin in sputum, the loss of glycerol dehydratase-
positive Lactobacilllus, and nuclear factor kappaB as factors related to lung inflammation 
in COPD.30-32  In addition, it has been found that precipitating sources such as ozone air 
pollution elicits a variety of identified mediators that can cause an alteration in circadian 
rhythm.  This disruption in the circadian rhythm was found by researchers which resulted 
in a cascade reaction from pro-inflammatory mediators causing inflammation in COPD.3 
Therefore, identification of which specific mediators of inflammation are responsible and 
how the process becomes ongoing and acute in COPD would help enable development of 
more effective treatment.8, 33  
 In particular, critically ill hospitalized adults with COPD are a vulnerable 
population who depend largely on the nurse and medical staff when it comes to 
identification on potential causes of an ECOPD.  Causes of ECOPD can range from 
infection, an external source (smoke or air pollution) in the environment, or an acute 
progression of the disease.  No theoretical framework specific to mediators signaling 
inflammation causing COPD was found in the literature.  Theories that are available 
focus on the care of symptoms and functional disability subsequent to COPD.  Coleman 
et al.  addressed the use of the Chronic Care Model with its aim to improve patient to 
physician and nurse relationship for better patient outcomes.34  Nursing’s essential role in 
care of these patients encompasses carrying out interventions, education, and 
reassessment of outcomes. These aspects are important in order to promote health 
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through prevention (avoidance of noxious airborne pollutants), recovery when there are 
exacerbations, and to help reduce severity of ECOPD as well as further decline in their 
pulmonary status. 
Epistemological principle 
 A concept that has a sound epistemological principle is clearly defined and 
discernible from other concepts.6 Inflammation, as a concept related to COPD, is defined 
as chronic inflammation of airways and lung tissue that alters gas exchange.35 
Characteristic clinical features that can be indirectly measured and described, including 
dyspnea, cough, and limited activity tolerance.  The degree of COPD severity can be 
graded as established in guidelines by GOLD.8  Clinical features such as air flow 
limitation that define COPD are also shared by other pulmonary diseases. Air flow 
limitation is also present in asthma, cystic fibrosis, and constrictive bronchiolitis.36  The 
mediators(s) that is responsible for air flow limitation among these pulmonary diseases is 
what is different. Distinctly, impaired air flow limitation creates shortness of breath and 
decreased activity tolerance.37  In COPD, there is no definite set of mediator(s) that can 
be pinpointed as being attributable to the abnormal inflammatory process. 
 Shortness of breath also referred to as difficulty breathing or breathlessness is 
common attribute of COPD. Some patients describe these acute episodes of shortness of 
breath as near death experiences.38  Others have made an effort to quantify the degree of 
shortness of breath. One instrument that patients can rate their level of shortness of breath 
is the Borg scale that gives patients a range of 0 to 10, with 0 being no effort in breathing 
and 10 maximal feeling of difficulty breathing.17 
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 Impaired functional endurance in patients with COPD is another predominate clinical 
attribute. Decreased activity tolerance impacts individuals with COPD in their ability to 
ambulate, do grocery shopping, and as the disease progresses getting to the bathroom or 
kitchen become a major hurdle. Two measurements of shortness of breath include the 
Borg visual analog scale that scores level of dyspnea from 0 (none) to 10 (severe).39 
Another instrument to measure activity tolerance includes body mass index, degree of 
air flow obstruction and dyspnea, and exercise capacity index (BODE).40 
Pragmatic principle 
 The concept needs to be relevant in the realm of scientific inquiry in order to fulfill the 
criteria for the pragmatic principle.6 Here the concept of inflammation is known to be a 
process that occurs as a result of infection, tissue injury from various airborne noxious 
stimuli, or para-inflammation that is likely responsible for autoinflammatory diseases.1 
Most currently cellular and molecular mediators are being found as the culprit of 
inflammation found in COPD. In the disease process of COPD, inflammation is defined 
for what it is; abnormal and chronic, with acute episodes involving the peripheral 
airways and lung parenchyma.19 Additionally, to fulfill the pragmatic principle, a 
concept must be well-operationalized, in that it can be measured. Therefore, to examine 
the consequences of inflammation involving COPD, indirect measurements can be 
obtained by using the following parameters: results of arterial blood gases, pulse 
oximeter readings, observational assessment for degree of respiratory distress, activity 
tolerance, and level of consciousness.  Inflammation in COPD is not completely a 
mature concept since at this time the responsible mediators that trigger the inflammatory 
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process are not all completely understood.  Also, there are a lack of universal standards 
to measure inflammatory mediators, based on the evidence found in the literature.  
Results 
 This paper uncovers the gap of what mechanisms are responsible for the chronic 
and acute inflammatory process related to COPD. Oh and Sin proposed that phenotyping 
patients with COPD could help target which specific mechanisms are linked to an 
individual’s cause of inflammation.19  Despite a multitude of different mediators reported 
in the studies, the findings are not conclusive. The implications of external, internal 
factors along with genetic implications play a role in mediators that malfunction causing 
airway inflammation in COPD.  Therefore, gaining knowledge of the mechanisms for the 
inflammation process gives a deeper foundation to the concept of inflammation. Nurse 
research scientists have a pivotal role in collaborating with other researchers in the 
discovery of mechanisms in COPD inflammation, as well as treatment modalities.41 It is 
important to recognize that the analysis of inflammation is fluid, since science is a 
dynamic process with new discoveries in pathogenesis that can improve assessment and 
treatment modalities for those with COPD. 
Conclusion 
 The principle-based concept analysis provided a rigorous process to examine the 
principles that comprise the concept of inflammation. No consistent theoretical definition 
was found for mediators responsible for the abnormal inflammation in COPD.  Each 
principle was examined based on the empirical data found in the literature illustrating the 
heterogeneous nature of mediators connected to the altered pathophysiology of 
inflammation among patients with COPD. Emphasis on further scientific research is 
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needed by nurses, physicians, respiratory therapists, and bench scientists to work together 
in phenotyping individuals with COPD in order to identify the specific mediator(s) 
eliciting and perpetuating the destructive inflammatory process.  In the future, 
phenotyping could be linked to treatments aimed at specific identified mediators which 
could be more effective in slowing the chronic inflammation in COPD and helping to 
prevent AECOPD occurrences. 
Relevance to clinical practice 
•   Identification of the attributes, antecedents, and outcomes of inflammation in 
COPD is essential to the clinical practice of nurses caring for these patients. The 
principle-based concept analysis of inflammation, as evidenced by various 
mediators, is the foundation of further research.  
•   A historical and scientific background provides a comprehensive framework to 
problem solving of this debilitating lung disease that is an international health 
burden. Nurses working together with other health care disciplines and scientists 
have the potential to improve health care delivery and quality of life for 
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Table 2. Observation Instrument to Assess Dyspnea - Respiratory Failure20  
  
























labored,  grunting  or  
apneic  periods  
Cyanotic:  lips,  nail  
beds,  mucus  
membranes  





Abnormal inflammation in COPD 
result of various causes: noxious 
stimuli such as air pollution 
(outdoor, indoor, and 
occupational), cigarette smoke, and 
a1 antitrypsin deficiency (an 
inherited disorder).  
 
Noxious stimuli or genetic disorder 
that trigger inflammatory mediators 
in lung tissue resulting in COPD. 
 
Exacerbations of COPD from 





Airway inflammation that is 
chronic and contributes to the 
progressive decline of lung 
function.  
 
Acute ECOPD episodes signals a 
worsening of the disease 
progression. 
 
Cough with or without sputum, 
dyspnea, and impaired exercise 
tolerance. 
 
Phenotypes of COPD: mixed 
COPD-asthma, emphysema-






Acute exacerbation of COPD: acute 
impaired gas exchange (hypoxia 
and/or hypercapnia), respiratory 
failure, need for supplemental oxygen 
delivery, ventilator assistance 
(mechanical ventilation or bi-level 
positive airway pressure (BiPAP). 
 
Anxiety and depression contributes to 
perceived impaired quality of life 
Increase in morbidity and mortality. 
 
Social and financial burden to the 
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Background: Discharge instructions for hospitalized patients with chronic obstructive 
pulmonary disease (COPD) are essential to promote improved health outcomes, reduce 
incidence of rehospitalization, and improve perception of quality of life (QOL). 
Objectives:  This study evaluated the feasibility of implementing the American Lung 
Association’s modified COPD Action Plan and assessment of QOL among participants 
hospitalized for an acute exacerbation of COPD (AECOPD) or COPD. 
Methods: A feasibility study was conducted on a cohort of critically ill participants with 
COPD hospitalized on a Progressive Care Unit. Nurses were trained to deliver the 
modified COPD Action Plan, and the Principal Investigator administered the World 
Health Organization Quality of Life-Brief (WHOQOL-BREF) questionnaire to assess 
QOL before discharge and 30 days after discharge via phone call. RE-AIM (Reach, 
Effectiveness-Adoption, Implementation and Maintenance) Framework was used to 
evaluate outcomes. 
Results: In hospital enrollment (n = 50 participants); 13 completed both the in-hospital 
and 30-day follow-up assessments. There was in hospital dropout (n = 1), reported deaths 
on 30 day follow-up (n =2) and those not reached by phone (n = 34).  Participants’ 
answer to whether self-management skills were learned from the action plan (12; 92.3% 
answered “Yes”). WHOQOL-BREF scores were compared using the Wilcoxon signed-
ranks test; there were no statistically significant difference between in hospital and 30 
day follow-up scores. 
Conclusions: Administration of COPD instructions can increase patient satisfaction in 
receiving self-management instructions from an action plan near time of discharge based 
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on a small follow-up sample.  There was no significant change in QOL scores obtained 
from the follow-up group in this study. Keywords: COPD, action plans, education, self-




Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory 
lung disease that results in airflow limitation, which is treatable but presently not curable 
(Celli et al., 2015).  The physical, psychological and economic burden of living with 
COPD negatively affects the QOL of patients and their caregivers. COPD is the third 
leading cause of death in the United States, and management of the disease remains 
suboptimal (National Institutes of Health, 2013).  Tremendous financial responsibility 
exists for both patients and the health care system, due to the high consumption of 
resources (Jennings et al., 2014). The average US hospital readmission rate within 30 
days post discharge for COPD is reported at 20.2%, and Centers of Medicare and 
Medicaid (CMS) have established penalties in financial reimbursement to hospitals for 
these readmissions, necessitating more effective chronic care management for these 
patients (Centers of Medicare and Medicaid, 2014).  Action plans are strategic 
instructions used to help nurses educate patients on disease entities and symptoms with 
information on appropriate actions to take.  A goal of action plans, as in COPD, is to 
teach self-management skills in order for patients to prevent delay in seeking care and 
worsening outcomes of morbidity and mortality (Sanchez et al., 2016). 
Based on the diverse needs and backgrounds of patients with COPD, it is essential 
to deliver discharge instructions individually (Hanania, 2012; Sheppard et al., 2013).  A 
compounding factor, however, is that many individuals with COPD, are of low-
socioeconomic status (City Data, 2015; Gershon, Dolmage, Stephenson & Jackson, 
2012).  Low-socioeconomic status encompasses lack of education, economic resources, 
and occupational risks (Gershon, Dolmage, Stephenson & Jackson, 2012).  Thus, concise 
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discharge instruments are needed to specifically provide COPD self-care instructions to 
improve QOL (Kansagara et. al, 2011).  Incorporating consideration of compounding 
factors such as comorbidities, socioeconomic status, and anxiety mostly related to 
breathless episodes, into discharge instructions is critical to gaining effectiveness and 
satisfaction in the delivery of nurse-patient education to patients with COPD (Coventry, 
Gemmell, & Todd, 2011; Polster, 2015). 
The purpose of this study was to evaluate the feasibility of implementing the 
American Lung Association (ALA) modified COPD Action Plan (page 1 of 2) as a 
systematic discharge education of patients with COPD and to assess their QOL using the 
WHOQOL-BREF (ALA, 2013; WHOQOL-BREF, 1997).  This structured discharge plan 
targeted patients with COPD receiving care in an acute care setting.   
Gap in Evidence 
Based on the literature, there is a growing body of evidence to support the 
effectiveness of specific patient education and discharge instructions, such as the use of 
action plans, delivered during outpatient visits or hospitalization (Almago & Castro, 
2013; Mularski et al., 2012).  For example, action plans for asthma have been studied for 
their educational impact on respiratory symptoms and self-management outcomes. In a 
meta-study, Jalota and Jain (2016) report that 400 asthma action plans have been 
investigated as to their effectiveness in teaching self-management of symptoms compared 
to data published from 69 studies on COPD action plans.  These findings on asthma 
action plans indicated effectiveness in prevention of more severe asthma exacerbations 
but little information was available on QOL.  In comparison, researchers concluded 
COPD action plans are likely to be effective if they are patient-centered and COPD-
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specific, take into account comorbidities, and have a multidisciplinary approach (Jalota & 
Jain, 2016). 
Mixed Evidence: Benefits, Inpatient or Outpatient, Evaluation of QOL 
Similarly, COPD action plans are beneficial to patients, but they too are limited in 
outcomes on QOL, based on a review of action plans and the role of antibiotics in self-
management for patients with AECOPD (Jalota & Jain, 2016).  Bischoff et al. (2011) 
reported use of a COPD action plan given to 252 participants who also received either 
hospital-based exercise or home-based exercise for patients in a one year prospective 
cohort study.  Reduced ECOPD recovery time (0.0001) was reported but the action plan 
did not impact unplanned healthcare utilization (OR 0.94, 95% CI 0.49 to 1.83) (Bischoff 
et al., 2011).  There was no report of QOL evaluation as noted by Bischoff et al. (2011).  
Sanchez-Nieto et al. (2016) conducted a multicenter, randomized study that taught self-
management skills to 85 outpatients, providing one group teaching session and then 
subsequent individual teaching sessions.  QOL was assessed using the COPD Assessment 
Test (CAT), (p = 0.286).  Findings reported by Sanchez-Nieto et al. (2016) included 
incidence of hospitalization for ECOPD in comparing control group (CG) to intervention 
group (IG) decreased, 52 versus 42. 
Benefits of COPD education.  Findings from a prospective study conducted over a one 
year period, used a COPD self-management education plan, by Labrecque et al. (2011).  
The same researchers reported 57 outpatients with stable COPD showed a decrease in 
emergency department (ED) visits compared to 45 patients who did not receive 
instruction (p = 0.002) (Labrecque et al., 2011).  Hospitalizations were reduced in the 
education group, but this finding was not statistically significant (p = 0.17), and 
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improvements in health-related quality of life (HRQOL) (p < 0.001) were observed.  
Similarly, Scott and colleagues (2011) compared knowledge of COPD and information 
needs of 38 inpatients and 43 outpatients with COPD diagnosed 9 +/- 7 years prior and 
measured these outcomes using two questionnaires.  Reported results showed a positive 
correlation between prior COPD learning and high school education (p < 0.05), and a 
positive correlation was found from prior COPD instructions and lower Lung Information 
Needs Questionnaire (LINQ) score (p < 0.01). The need for further education on diet and 
self-management was identified.  No measurement of QOL was reported by Scott et al. 
(2011). 
In cross-sectional descriptive study, Choi, Chung, and Han (2014) taught 126 
participants with COPD during clinic visits how to care for their respiratory condition 
and prevent ECOPD.  Results suggested improved adherence to an action plan and 
reduced unplanned hospitalizations (p = 0.001).  QOL measured with St. George’s 
Respiratory Questionnaire (SGRQ) results mean (standard deviation) 37.79 +/- 18.99.  
Trappenburg et al. (2011) conducted a multicenter randomized controlled trial to test the 
effectiveness of administering personalized COPD action plans to reduce exacerbation 
recovery time in 233 patients.  Patients were recruited during scheduled outpatient visits 
(n =111) in the individualized action plan and (n = 122) usual care.  SGRQ was used to 
report QOL in this study (p = 0.42).  Every three days participants completed the Clinical 
COPD Questionnaire (CCQ) to measure health status, starting as out-patients and then at 
home or if they were hospitalized. Results of the CCQ scores indicated improvements in 
health status related to a decrease in exacerbations (p ≤ 0.01).  Ko et al. (2016) carried out 
a randomized controlled trial to assess the impact of a comprehensive intervention for 
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patients recently discharged from the hospital for AECOPD.  Compared to the control 
group that received standard instructions, the group receiving the intervention 
experienced a reduction in hospitalization for AECOPD (p = 0.047) and decreased length 
of stay (LOS) (p ≤ 0.001).  The investigators did not report what particular aspect of the 
intervention was most effective. 
Sanchez-Nieto et al. (2016) conducted a randomized controlled trial that enrolled 89 
patients, who months prior, had either been hospitalized for ECOPD or treated in the 
emergency department (ED).   These researchers found incidence of ECOPD, in the 
intervention group, decreased from 52 to 42 (Sanchez-Nieto et al., 2016). 
Fan et al. (2012) conducted a randomized controlled trial of patients with COPD 
who had been hospitalized within 12 months prior to enrollment for COPD. The 
comprehensive program educated 209 participants in the intervention group to self-
initiate antibiotics and prednisone for ECOPD and 217 in the usual care group.  When it 
was identified that the mortality rate was higher in the intervention group 28 compared to 
10 receiving usual care the study was stopped (Fan et al., 2012).  This outcome was not 
defined but surmised that participants in the intervention group may have been over 
confident in self-treatment and delayed seeking medical care. 
Best Practice Discharge Models:  Reducing Hospital Readmissions and Improving 
Outcomes 
The COPD Foundation held a multi-stakeholder National COPD Readmissions 
meeting in 2013 to establish evidence-based practices to reduce hospital readmissions.  
Krishnan et al. (2015) reported that no specific evidence-based COPD educational 
instruments were produced from this meeting.  Evidence-based programs were identified 
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to educate on disease symptoms and actions to take, as well as scheduling post-hospital 
office appointments included: Society of Hospital Medicine’s (SHM), Project Re-
Engineering Discharge (RED), Care Transitions Intervention, Project Better Outcomes 
through Optimizing Safe Transitions (BOOST), and the Transition Care Model.  
Providing an individualized approach to educating self-management for patients with 
COPD was emphasized along with identification of comorbidities such as congestive 
heart failure (CHF) and diabetes (DM) which pose challenges to self-management of 
COPD (Krisman et al., 2015).  
Furthermore, findings were reported from several studies that multidisciplinary 
educational action plans which included evaluation of QOL, physical exercise, and 
follow up phones calls to patients after discharge, decreased hospitalizations (Krishnan et 
al., 2015).  Evidence of these comprehensive discharge programs revealed bundle 
interventions (education, exercise, and follow up phone calls after discharge) such as 
BOOST for COPD patients, reporting a 2% 30-day hospital readmission reduction 
(Krisman et al., 2015).  Incidentally, BOOST does not include home visits. Results 
reported improved outcomes, fewer hospitalizations, and increased QOL (Hansen et al., 
2013). 
Mularski et al. (2012) examined comparative effectiveness research for patients 
with COPD reporting gaps in evidence on effective education strategies such as proper 
instruction on use of inhalers, setting follow-up appointments after discharge and 
evaluating QOL.  They called for collaboration among researchers, clinicians, payers, and 
policymakers in broadening methodologies such as repeating performed effectiveness 
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designs that examine longitudinally over time positive and negative outcomes, as well as 
expense (Mularski et al., 2012). 
COPD action plans are promising to patients with COPD, helping them acquire 
knowledge, increase their confidence in managing their lung disease, and deciding when 
to contact health care providers. However, few studies have confirmed whether specific 
action plans for COPD delivered as discharge instructions are an effective approach to 
reduce hospital admissions and influence quality of life (Bischoff et al., 2011; Effing et 
al., 2012; Jennings et al., 2014). Future studies are needed that detail implementation and 
content of instructions (pharmacological and nonpharmalogical), and how discharge 
instructions could be individualized based on assessment of prior participant knowledge 
of self-management and evaluation of QOL (Effing et al., 2012; Mularski, 2012; Polster, 
2015). 
As important as it is to assess outcomes on health, it is equally as important to 
assess the feasibility of instructional models and their uptake during discharge.  Another 
consideration, is a need for uniformity in delivering COPD discharge instructions (either 
written, audiovisual, or electronic tablet-based) to improve self-management among 
patients with COPD (Choi et al., 2014; Mularski et al., 2012).  The present study sought 
to provide an initial understanding of the feasibility of delivering one type of action plan 
to critically ill patients with COPD and whether there are perceived benefits on QOL.  
Specifically, the aims of this study were to 1) evaluate the feasibility of implementing the 
COPD modified Action Plan as part of the discharge instructions for patients with COPD 
or an exacerbation of COPD (ECOPD), hospitalized on a PCU;  
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2) compare QOL measured using the WHOQOL-BREF valid instrument and patient 
response scores before discharge, and at 30 days post discharge; and 3) explore 
discharged patients perceptions related to the action plan, regarding whether or how this 
instrument assisted them to gain knowledge of self-management with COPD (e.g., 
number of hospitalizations, emergency department (ED) visits, etc.).  Outcomes of this 
feasibility study were measured with the RE-AIM Framework. 
Theoretical Framework 
The Social Ecological Model (SEM) was used to guide the development of the 
structured discharge educational protocol and QOL evaluation for the present study 
because SEM recognizes the interconnectedness in layers of influence for patients with 
COPD (Centers for Disease Control and Prevention, 2015).  The framework consists of 
multiple levels of influence which include: the individual, his/her knowledge, motivation 
and skills; interpersonal relationships that consists of family, friends and social network; 
organizations, involving environmental factors (home or work) such as air pollutants 
indoors and outdoors.  Additionally, community resources are composed of connections 
and support between organizations in the community and home.  Public policies embody 
the laws to support and protect individuals and communities (Glasgow, Vogt & Boles, 
1999). The SEM provided a schematic design as to the interrelationships of factors to be 
considered when this discharge intervention was developed to teach hospitalized patients 





What is the outcome of using the ALA COPD Action Plan in terms of self-rated 
knowledge and assessment of QOL in a cohort of patients discharged after hospitalization 
for an AECOPD or COPD? 
Methods 
Study Design 
This prospective feasibility study used the ALA COPD modified Action Plan for 
discharge instructions to evaluate the outcome on patients hospitalized for an AECOPD 
J44.1 International Classification of Diseases (ICD) or for another illness, or had COPD 
J44.9 ICD as a secondary diagnosis.  In addition, QOL was assessed using the 
WHOQOL-BREF questionnaire before hospital discharge and 30 days via phone call, 
after hospital discharge.  The study was conducted over six months (May, 2016 to 
October, 2016) in a 24-bed PCU at a hospital in Kansas City, Missouri.  Prior to this 
study there was no formalized COPD action plan in place for nurses to review and 
provide to patients with COPD on discharge from the hospital.  The study received 
expedited approval from the Medical University of South Carolina’s institutional review 
board (IRB) and the hospital’s research operating committee.  Informed consent was 
obtained from all participants. 
Setting, Sample and Recruitment 
Participants were recruited from a 24-bed PCU located in an urban area of 
western Missouri that serves a population 473,000 of racially diverse individuals (City 
Data, 2013).  Among this population, most patients live within a 150 mile radius of the 
hospital in the urban and surrounding area (Research Medical Center, 2016).  City data 
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(2015) reported that 14.3% of Kansas City residents live with income below the poverty 
level, as compared to 11.7% for the whole state.  It was anticipated that retention of the 
sample would be a challenge in the 30 day follow-up based on follow-up in previous 
studies at the hospital where the study was conducted (Feeback, 2015).  The original 
sample size of 25 was doubled to 50 to obtain adequate data to evaluate the feasibility of 
this study (Billingham, Whitehead & Julious, 2013). 
A majority of this population with COPD have multiple comorbid conditions: 
renal disease, diabetes, congestive heart failure, and depressive symptoms (Maters, 
2014).  Inclusion criteria included adults: 18 years-of-age and older, discharged to self-
care, home (independently or with family/significant other), have a primary or secondary 
diagnosis of exacerbation of AECOPD (J44.1 ICD) or COPD (J44.9) International 
Classification of Disease (ICD-10, 2011), score 15 on the Glasgow Coma Scale, 
understand and speak English, have access to a working phone, and have an address to 
receive mail.  Exclusion criteria consisted of patients with a tracheostomy, not able to talk 
or communicate using BiPAP (noninvasive bi-level positive airway pressure ventilation) 
during the day or on mechanical ventilation. (Table 1. Provides the inclusion and 
exclusion criteria for enrollment of participants). The Principal Investigator (PI) screened 
potentially eligible patients with COPD from a daily census sheet, invited those who met 
the inclusion criteria to participate, and obtained informed consent from those who 
agreed.  Demographic characteristics measured: age in years, gender, race, smoking 
status, home oxygen use, body mass index (BMI) in kg/m2, marital status, home support, 
education level, employment status, primary and secondary diagnosis ICD-10 codes were 




RE-AIM. To measure feasibility of this discharge instruction, the RE-AIM 
framework was used (Glasgow, Vogt & Boles, 1999). Assessment of feasibility was 
evaluated over various time points, such as after delivery of the action plan via the 30 day 
follow-up phone call post discharge.  Reach included recruitment and retention of the 
sample population of participants with COPD hospitalized on a Progressive Care Unit 
(PCU).  Effectiveness was measured by assessing participants’ perceived benefits of the 
COPD Action Plan, based on 30 day follow up feedback (survey and qualitative results).  
A trained PCU nurse completed a questionnaire on how beneficial the discharge 
intervention was perceived for participants with COPD and answered questions to 
evaluate acceptance and feasibility of the action plan.  Adoption was evaluated by PCU 
nursing staff (rated responses) and participants’ perception of willingness to adopt the 
discharge clinical procedure (rated responses and 30 day outcomes of health care 
utilization and QOL outcomes).  Implementation of the clinical procedure was appraised 
by consistency in delivery (fidelity) of the COPD discharge procedure, given direct 
observation, feedback from participants, and the nurse’s recommendations.  
Maintenance will be determined following completion of this study’s results from the 
trained PCU nurse and participants’ evaluations of the COPD Action Plan as an approved 
institutional discharge procedure for patients with COPD (survey and qualitative results).  
Quality of life. WHOQOL-BREF questionnaire includes 26 items that were read 
and completed by the PI with the participant (Appendix II). The questionnaire assesses 
QOL in four domains: physical, psychological, social relationships, and environment 
(World Health Organization, 2014).  WHOQOL-BREF questionnaire was selected for its 
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documented sound psychometric properties and diverse application with adults sick and 
well, and tested in 23 countries from the general population consisting of hospital, 
rehabilitation, and outpatient settings (Skevington, Lotfy, & O'Connell, 2004).  
Validation of the psychometric properties of this assessment instrument has been verified 
in a cross-cultural adult survey (n = 11,830).  Cronbach’s a was acceptable (p> 0.7) for 
internal consistency reliability. The analysis was based on Multi-Trait/Multi-Item 
Analysis Program (MAP).  Construct validity based on Pearson correlations (one-tailed 
test) between domains for the total sample was strong, positive, and highly significant (p 
< 0.0001) (Skevington, Lotfy & O’Connell, 2004, p. 305). 
Hawthorne, Hermann & Murphy (2006) reported guidelines for interpretation of 
WHOQOL-BREF domain scores from two studies of adults in the community 
categorized by gender, years of age, and health status.  General norms for the WHOQOL-
BREF were: 73.5 (SD, 18.1) physical domain, 70.6 (SD, 14.0) psychological wellbeing, 
71.5 (SD, 18.2) social relationships, and 75.1 (SD, 13.0) environment.  Differences in 
WHOQOL-BREF domain scores were significant when reported by health status and 
decreased by 50% compared to those in excellent health (Hawthorne, Hermann & 
Murphy, 2006). 
Each participant was sent a postcard 14 days following discharge to remind them 
of the 30 day follow-up phone call. (Figure 1). Participants were asked questions by the 





COPD Discharge Education: COPD Action Plan and Monthly Calendar 
The modified COPD Action Plan provides three classifications for patients to 
daily self-identify changes in respiratory symptoms and takes action based on changes in 
their respiratory condition (American Lung Association, 2013) (Table 2).  Color zones 
included: 1) Green Zone, patient is doing well/action take daily medications, 2) Yellow 
Zone, patient is having a bad day/action: use immediate relief inhaler, call health care 
provider immediately if symptoms worsen, 3) Red Zone, need for urgent medical 
care/action: call #911 immediately and use immediate relief inhaler until help comes.  
A monthly calendar was given to each participant to record daily with a check 
next to the symbol representing the following: respiratory condition and well-being 
described per ALA color zones, hospitalizations, ED visits, phone calls to health care 
provider, etc. (Table 3).  The calendar was to be returned after the 30 day follow up call 
to the participant, in a hospital addressed stamped envelope provided by the PI. 
Procedures for COPD Discharge Education 
Three PCU nurses who volunteered to deliver the COPD discharge instructions 
were trained individually.  Nurses were informed about the purpose of the study and 
entire study flow. The PI provided a standardized script for use with each participant in 
this study to the nurse volunteers, and demonstrated the process of administering the 
discharge action plan. The nurses were notified when patients enrolled and consented in 
the study, and then requested to deliver the discharge education close to the time the 
participant was to be discharged or on the day of discharge. The modified COPD Action 
Plan was read to participants the day of or before discharge by the PI or trained nurse. 
The participant was asked to “teach-back” in their own words, to describe what each zone 
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represented in symptoms and the action to take. This clinical procedure took place in the 
privacy of the participant’s hospital room. 
Participants were provided with a monthly calendar to document daily symptoms, 
and were instructed how to complete it. The PI administered the WHOQOL-BREF 
questions after the modified COPD Action Plan instructions had been reviewed with each 
participant.  A copy of the action plan was then given to the participant to take home and 
place in a prominent place as a guide to daily self-assessment.  
As a component of the feasibility evaluation the trained PCU nurse who delivered 
the action plan completed an evaluation form on adoption and implementation of this 
discharge procedure.  The evaluation was done two days after they conducted the 
discharge education. (Table 4) 
Delivery of COPD Action Plan 
The Principal Investigator (PI) obtained lists of potentially eligible patients with 
COPD from a unit census sheet.  Patients meeting inclusion criteria were invited to enroll 
in the study. Those who agreed to participate, signed the informed consent. 
The PI read the WHOQOL-BREF questionnaire to the participants and recorded 
their responses.  Next the PI read the information to be filled in daily on the monthly 
calendar by the participant.  Then the participant’s address was recorded on a postcard to 
be sent to him or her 14 days after discharge as a reminder of the 30 day follow up via 
phone call. Participants received $5.00 gift card following completion of the instructions 
and responding to WHOQOL-BREF questionnaire. Data were entered into a Research 
Electronic Data Capture (REDCap) database, a secure web-based data management 
system used for data capture from research studies (REDCap, 2015). The PI followed up 
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with each participant by telephone, 30 days after discharge to collect data from the 
monthly calendar, namely the number of office visits (scheduled and unscheduled), 
emergency department visits, and hospitalizations.  The WHOQOL-BREF questionnaire 
was re-administered to participants and responses recorded by the PI.  Participants’ 
scores of satisfaction were obtained related to their perceived satisfaction with the 
delivery of action plan instructions and to evaluate their perceived gain in knowledge 
regarding self-management skills to care for their COPD.  After questions were 
answered, a $5.00 gift card and stamped hospital addressed envelope was sent to the 
participant to return the completed calendar. 
Data Analyses 
Quantitative data 
All data were collected by the researcher and directly entered into the Research 
Electronic Data Capture (REDCap) study database.  Statistical analyses were then 
performed using the Statistical Package for the Social Sciences (SPSS) 23.0 (IBM SPSS, 
Armonk, N.Y.).  Descriptive statistics were calculated for each variable. For continuous 
variables, means, standard deviations (SD), medians, and minimum and maximum values 
were calculated. For categorical variables, counts and percentages were calculated.   
The WHOQOL-BREF scoring methodology was guided by a published handbook 
(WHOQOL-BREF, 1996). Missing data were handled appropriately, < 20% of raw scores 
missing in a domain resulted in no domain score. Domain scores were calculated from 
item raw scores for each characteristic and each domain in accordance with the scoring 
methodology. The calculation to transform each domain score was done with an algebraic 
equation.  Each item in the domain had a response score from 1 to 5, on a Likert scale.  
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The actual raw score was subtracted by the lowest possible raw score of that participant 
and then divided by the possible raw score range, next that sum was multiplied by 100.  
Scores were transformed linearly 0 to 100.  The transformation score with calculated in 
REDCap before exporting into SPSS. 
WHOQOL-BREF in hospital scores were compared to the 30-day follow-up 
assessment domain scores by using the Wilcoxon signed-ranks test.  Wilcoxon signed-
ranks test was used to compare the ranks from four QOL domains of participants who 
completed the WHOQOL-BREF in hospital after the modified COPD Action Plan 
education session and to 30 day follow up via phone call after discharge.  Differences 
were considered statistically significant if the test statistic had a probability level of 0.05 
or lower. In addition, a 95% confidence interval was calculated for all of the mean 
difference scores.  The two sample t-test was used to compare the sample that completed 
the QOL questionnaire domains (physical, psychological, social relations, and 
environment) in hospital and 30 day follow-up via phone call. 
Qualitative data  
This study utilized qualitative description to analyze the verbal data obtained from 
participants during the 30-day call back, as open ended comments (Sandelowski, 2000). 
The question to obtain verbal text, was the first among the survey and QOL questions 
asked.  The PI and a qualitative mentor read and reviewed all of the comments.  Having 
two researchers review the open-ended comments increases the trustworthiness and 
confirmability (Krefting, 1991).  The expertise of the PI being a bedside nurse on the 
PCU for greater than ten years (prolonged engagement) helped to establish 
trustworthiness among the participants (Krefting, 1991).  The external audit of the data 
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(participant responses) appraised by a senior qualitative mentor who verified 
confirmability of the themes that emerged.  All data for verbal responses (n =10) was 
transcribed in writing by the PI on a hard copy of the WHOQOL-BREF during the 
follow-up phone call, which was then kept in each participants’ file to provide an audit 
trail.  The construct was measured by face validity, a subjective form of validity, 
pertaining to the question and responses by participants.  The construct of interest 
measured satisfaction and benefit of participants receiving self-management instructions 
from the modified COPD Action Plan.  There were no test-retest measurements to 
provide evidence for reliability of this question. 
Results 
Demographics and Participant Characteristics 
A total of 68 patients were approached, 50 agree to participate, 50 were enrolled 
and 13 completed the 30 day follow up phone call. (Diagram I Illustrated the sample 
population by Consolidated Standards of Reporting Trials (CONSORT).  Demographic 
characteristics (Table 5) of the sample were: age (mean, 64.5 year; SD, 9.5 years), range 
was 49 years to 84 years, and gender: 26 (52%) females and 24 (48%) males.  Of race 
there were, 18 (36%) were African American/Black and 32 (64%) White. Among 
participants, 19 (39.6%) answered, ‘yes’ to smoking status and 29 (60.4%) answered, 
‘no’.  Those who used home oxygen, reported, ‘yes’ 19 (39.6%) and ‘no’ to home oxygen 
use 29 (60.4%).  Body mass index (BMI) in kg/m2 recorded on participants, minimum 
13.9 and maximum 70.0, (mean, 24.4; SD, 11.4).  Marital status was self-reported by 
participants as: 28 (56%) single, married 17 (34%), and divorced 5 (10%).  Having home 
support, participants who lived with someone assisting them with activities of daily 
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living, 14 (29.2) ‘yes’ and 34 (70.8%) ‘no’.  Education level was reported as followed: 
some high school 34 (69.4%), some college 10 (20.4%), completed college 4 (8.2%), and 
graduate school 1 (2.0%).  Employment status of those not working 41 (83.7%) and those 
working 8 (16.3%).  Documented primary and secondary diagnosis with International 
Classification of Diseases (ICD-10) codes were collected from participants’ medical 
record. Primary diagnoses included: acute respiratory failure 10 (20%), AECOPD 4 (8%), 
Healthcare-Associated Pneumonia 4 (8%), acute and chronic respiratory failure 3 (6%), 
acute or chronic respiratory failure 3 (6%), and ECOPD 3 (6%).  Secondary diagnoses 
were documented as followed: COPD 19 (38%), ECOPD 13 (26%), AECOPD 7 (14%), 
and hypoxia 2 (4%). 
There were a total of 37 dropouts. One participant dropped out while in the 
hospital, who did not complete the WHOQOL-BREF questionnaire after being enrolled, 
while 34 others did not complete the 30-day follow-up assessment, and 2 deaths were 
reported during the 30-day follow-up via phone assessment.  
Feasibility Assessment.  The RE-AIM framework was used to evaluate five dimensions, 
beginning with reach, and defined as recruitment and retention. (Table 6).  The target 
sample of 50 participants were recruited, however only 13 were retained.  Of the patients 
that dropped out or could not be contacted at the 30 days visit; 1 dropped out in the 
hospital, 2 died and 34 were not able to be reached by phone call on follow-up, or refused 
to complete the 30 day follow-up survey and WHOQOL-BREF reassessment due to not 
feeling well or being busy.  Effectiveness, defined as outcomes and perception of benefit, 
was assessed with the following question, “Do you think the discharge action plan taught 
you to better take care of your respiratory symptoms and when to seek help?” Participant 
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responses were yes 12 (92.3%) and no 1 (7.7%) participant response was “It didn’t cure 
me.”  Satisfaction with the modified COPD Action Plan and delivery by participants was 
rated, high 4 (30.8%), moderate 9 (69.2%), and low 0 (0%). Based on qualitative 
comments from participants on 30 day follow-up, three themes emerged from the 
comments.  1) Perceptions about Delivery of  the modified COPD Action Plan reflected 
an appreciation of knowledge gained, two responses, “Person to person is always good” 
and “No one (before) took the time to go over this with me. I appreciate it.” 2)  
Participants discussed feeling better related to Improved Self-Management Skills with a 
participant stating, “Doing exceptionally well. Eating healthy and stopped smoking,” and 
another “Great.” 3) Consequences of Decline related to COPD, “When real hot out, slow 
deep breaths still don’t help.”   
One trained PCU nurse completed a follow-up survey. The response from the 
PCU nurse on “rated acceptability and ease of delivery of action plan,” was moderate 
because the nurse said based on each patient’s existing knowledge of COPD self-
management, educational background and general well-being, more explanation of the 
action plan instructions may be needed for some patients.  Reply by the PCU nurse to, 
“Do you see this action plan as a benefit for future patients with COPD?” Response was 
‘Yes’. (Table 7). 
Adoption was evaluated by rated responses and 30 day outcomes of health care 
utilization and QOL outcomes.  Wilcoxon signed-ranks test of median QOL scores 
indicated no statistical significance among domains (score of differences between means 
in hospital and 30 day follow-up).  The following are the domain scores (mean in 
hospital, mean 30 day follow-up and p value): physical (49.3; 55.8; p = .78); 
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psychological (64.8; 70.8; p = .40); social relations (60.0; 55.8; p = .79), and environment 
(70.2; 72.4; p = .59) Participants rating of satisfaction with action plan and delivery was 
high, 4 (30.8%), moderate, 9 (69.2%), and low, 0(0%).  Health care utilization post 
hospital, 30 day follow-up: number of ED visits: 12 (99%) no ED visits and 1 (1%) ED 
visits for an insulin reaction.  The number of reported hospitalizations following 
discharge, 12 (99%) no hospitalizations and 1(1%) hospitalized 2 days for COPD.  
Number of times participants called #911 since discharge was, 0 (100%), number of 
office visits reported were, 5 (40%) no visits, 7 (55%) had scheduled visits, and 1 (5%) 
had an office visit not related to COPD. (Table 8). Implementation was evaluated on 
consistency in delivery (fidelity) of the COPD discharge procedure, feedback from 
participants, and the nurse’s recommendations. 
Survey outcome of PCU trained nurse responses, post administration of the 
modified COPD Action Plan rating for length of time to deliver the action plan” answer 
by the PCU nurse was ‘15 minutes’. The PI observed the PCU nurse’s consistency 
(fidelity) according to scripted dialog in delivery of the COPD discharge procedure.  
Only one trained PCU nurse was observed due to limitation in availability of nurses when 
participants were enrolled in the study and ready to receive the discharge instructions. 
Maintenance was the final dimension to determine feasibility of the study. The 
discharge intervention could be considered a potentially strategic intervention using the 
ALA modified COPD Action Plan but use of the WHOQOL-BREF demonstrated no 




Quantitative findings (QOL).  Of the 30 day follow-up calendars, 2 were 
returned completed with the following results: participant (1) green was marked for good 
day = 88% (28 days out of 32 total days recorded), yellow marked for some problems 
breathing = 0.5% (2 days out of 32) and 3% (2 days out of 32, nothing was recorded). 
Participant (2) green marked = 64% (18 day out of 28 total days recorded), yellow 
marked = 36% (10 days out of 28).  SPSS was used to calculate results on the 
transformed domains in hospital (n = 49) and on 30 day follow-up (n = 13).  Scores 
below 70 would be considered a perceived low QOL, as indicated by the interpretation of 
WHOQOL-BREF scores from Hawthorne, Herrman & Murphy (2006).  The participants 
who completed the study on 30 day follow up (n = 13) rated social and physical domains 
as the lowest rated of the four domains, each with a mean 55.8, which is considered a low 
perceived QOL. 
The Wilcoxon signed-ranks test indicated that there was no significant difference 
in QOL between in hospital and 30 day follow up of 13 participants.  Thus, the null 
hypothesis is retained, as there is no difference between the ranks of in hospital QOL and 
30 day discharge follow-up QOL scores.  Since the sample (n = 13) of participants 
retained who completed the study was small, the standard deviation and the 95% 
confidence interval (CI) of the difference in mean scores (in hospital and 30 day follow-
up) was calculated to determine amount of difference.  Wilcoxon signed-ranks test was 
used to calculate the z scores.  CI and z score results of QOL domains were: physical (CI 
-7.3, 10.0), z = -.28; psychological (CI -5.4, 15.0), z = -.85, social; (CI -11.9, 9.4), z = -
.27; environment (CI -10.6, 5.8), z = -.54.  
81  
  
The WHOQOL-BREF mean score differences between in hospital scores and 30 
day follow via phone call scores were, physical (+1.4) and psychological (+4.8) indicated 
an increase in both domain scores though not statistically significant.  Increase in the 
mean score could indicate participants being more active at home, experiencing some 
physical improvement.  The psychological domain had the greatest increase in mean 
score (+4.8) of the 4 domains but was not statistically significant. This possibly reflects 
participants feeling better mentally being at home in familiar surrounds and for some 
being near family or loved ones.  Social mean domain difference in score of (-1.3) might 
reflect participants with less or no social support at home, as 17 (34%) participants 
reported being single.  Environment score (-2.4) may indicate poor air quality if exposed 
to smokers or poor housing conditions.  Differences in social and environment mean 
domain scores were not statistically significant. 
Qualitative findings (30 Day Follow Up) 
Participants were called at their requested time and day in accordance with the PI 
availability, which was scheduled with the PI during the in hospital portion of the study.  
Comments were evaluated from 10 out of the 13 participants who offered responses to 
the first question asked during the 30 day phone follow up.  Overall, most participants 
were weak and become short of air (dyspneic) during phone call, and would simply 
answer the rated questions for evaluation of the action plan and QOL questions.  The 
comments were summarized into themes relevant to the question concerning, satisfaction 
with receiving self-management instructions from the COPD Action Plan.  From the 
analysis of the data, words used by participants, three prevailing themes emerged as 
previously described. Since there was a small sample of participants who completed the 
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30 day follow-up call, and 10 out of 13 providing responses to one question, resulted in a 
scant amount of text to analyze.  Minimal responses from participants were due to them 
being weak and dyspneic from their COPD, and for many, having comorbidities.   
Discussion 
Overall findings from the study indicated the targeted PCU population was able to 
be recruited; administration of the modified COPD Action Plan was achievable by a 
trained PCU nurse and the PI. Obtaining participants QOL scores could be obtained when 
the PI read and recorded them at the bedside. The study had limited feasibility due to lack 
of retention in the 30 day follow-up. There were no significant differences from the QOL 
questionnaire mean scores before hospital discharge compared to 30 day follow-up per 
phone call.  Even though a small sample of participants completed the study (n =13), they 
reported positive satisfaction ratings with the instructions from the action plan.  Only one 
reported being hospitalized for a health issue not related to COPD.  In addition, from the 
qualitative data in the follow-up, three themes surfaced as described in qualitative 
findings. 
Although much emphasis has been made about the correlation of QOL to outcome 
measures of patients with COPD, there is inconsistency and lack of significant findings 
from self-management instructions on QOL.  Ko et al. (2016) reported, in their 
comprehensive intervention for patients recently discharged for an AECOPD, the 
intervention group showed a decrease in hospital readmissions and at 12 months a mean 
improvement of -6.9 points in total St. George’s Respiratory Questionnaire (SGRQ) 
measuring health-related QOL.  In comparison, researchers who used a COPD Action 
Plan found adherence to instructions was negatively associated with unplanned 
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hospitalizations but findings indicated no significant relationship with QOL scores (Choi, 
Chung & Han, 2014).  Trappenburg et al. (2011) found that use of an action plan, 
teaching increased knowledge among patients to identify symptoms of ECOPD, did not 
decrease healthcare utilization or improve health-related QOL.   Bischoff et al. (2011) 
and researchers studied the impact of using a COPD action plan for recognition of 
ECOPD symptoms, along with standing orders for prednisone and antibiotics, did not 
include an evaluation of QOL.  The lack of statistical improvement in QOL scores from 
the findings of this feasibility study and other published studies that examined QOL, begs 
the question, are most patients with COPD so impaired by their health (COPD and 
comorbidities) and/or their socioeconomic status that they do not perceive QOL 
improvement? 
Gaining insight into the perceptions of the participants was important to examine 
in relationship to the delivery of the COPD Action Plan, because the findings are relevant 
to the feasibility of the study.  Participants’ verbal acknowledgment in gaining real life 
self-management skills that could help improve their QOL, may also decrease their risk 
of hospitalization or rehospitalization for an AECOPD.  Maintaining privacy and nurse to 
participant interaction of the discharge protocol may have helped promote learning and 
satisfaction in the survey outcome measures, but no improvement in the QOL domain 
scores. Establishing trust among participants in their interaction with the PI, was a goal, 
in order that they would feel comfortable to ask questions and share their comments. 
Futhermore, the literature reports inconsistency on the content and benefit of 
education for patients with COPD, being disease specific or general as found in discharge 
models such as Re-Engineered Discharge (RED) toolkit.  The RED discharge model has 
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minimal instructions on actions for patients to take related to disease symptoms for 
COPD (RED, 2016).  Bischoff et al. (2011) reports limited positive outcomes using a 
written COPD action plan, from which there was no decrease in healthcare utilization 
among participants.  Fan and researchers (2012) reported their study being stopped 
because of a high mortality rate in the intervention group than usual care group, of those 
who received self-management instructions (pharmacological and nonpharmalogical).  
Such outcomes could indicate giving participants’ options to initiate pharmacological 
interventions for self-management of developing ECOPD symptoms can be potentially 
detrimental. 
While previous research suggests a need for ongoing communication with 
participants to support the action plan instructions, no time frames have been established 
(Bischoff et al., 2011).  This study noted that patients reported satisfaction related to 
implementation of the ALA modified COPD Action Plan, as noted in comments and 
ratings from patients.  The trained PCU nurse in our study found the action plan to be a 
reasonable protocol to administer to patients with COPD before or on the day of 
discharge. Therefore, we conclude that the COPD discharge protocol using an action plan 
is partially feasible in the acute care setting, but follow-up via phone call lacked 
feasibility, as shown by the insufficient retention of participants.  Dropouts in follow-up 
were an anticipated obstacle from previous studies at this hospital that did phone follow-
up.  The high dropout number rate could be a consequence of this population being high 
risk for multiple reasons: the severity of their COPD disease, comorbidities, 
socioeconomic factors, and unstable home environment. When participants were called 
for the 30 day follow-up, some refused to complete the survey and questionnaire stated 
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the following reasons; “I’m moving right now,” “I don’t feel well,” “Can I answer the 
questions for my husband (participant)?” and another participant was too drowsy.  Also, 
participants did not all want to answer the question rating satisfaction with their sexual 
activity and for some it created a distraction (they wanted to go into detail). 
Key components of this feasibility study merit future consideration and 
evaluation:  1) determining the optimal timing for  delivering COPD instruction, at least 
one day before discharge, 2) determining the effectiveness of a 15 to 20 minute patient 
education session to provide , concise content of ALA modified COPD Action Plan 
instructions, 3) evaluation of a more concise QOL instrument and  4) reconsideration of 
large incentives ($10 gift card) or meeting participants at office or clinic visits for follow-
up communication and evaluation from participants. 
The PI sitting down next to each participant to deliver the instructions, nurse to 
participant, provided an opportunity for participants to ask questions, which in some 
cases enabled valuable teaching.  In several cases the participants reported having 
difficulty getting appointments when they developed abnormal, non-emergent respiratory 
symptoms (increased dyspnea or colored sputum production).  In these instances, 
participants were instructed on options to seek medical attention such as urgent care 
centers or the emergency department.  The instruction session was preemptive to help 
most participants identify the connection between waiting too long to receive medical 
attention and hospitalization.  Likewise, participants were able to see the resulting 
detrimental effects of smoking or other airborne (indoor or occupational) inhalation 
irritants that may have led to their hospitalization, in some cases an AECOPD or 
respiratory failure.  Depending on participants’ educational and reading level, reading 
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comprehension was not assessed, reading to the participants insured the instructions of 
the action plan was conveyed, and a teach-back assured understanding.  Participants 
allowed the PI to read the QOL questionnaire while holding it in front of them and 
recording their answers, since most were weak and dyspneic.  Implementing an action 
plan on the day of discharge or a day before was best completed the day before discharge, 
when participants were not waiting for a ride and rushing to leave the hospital to go 
home.  Potential moderators affecting the outcomes of this study included: literacy of 
participants, time spent sitting at the bedside to deliver the action plan and obtaining 
responses from the QOL questionnaire, gift card, nurse to participant interaction, privacy 
of the participants’ room, severity of COPD, and time frame presenting information in 
most cases the day before discharge.  
WHOQOL-BREF is a 26-item comprehensive instrument to evaluate QOL.  The 
WHOQOL-BREF was selected for its documented validity and reliability to evaluate 
QOL and is among one of the more brief questionnaires available.  Comparing the 
WHOQOL-BREF to St. George’s Respiratory Questionnaire (SGRQ) that is a 50-item 
questionnaire and a shorter version of SGRQ, which is a 40-item questionnaire; the 
WHOQOL-BREF has fewer questions.  Due to the fact that this patient population suffers 
with dyspnea resulting in limited endurance and ability to concentrate in order to take in 
information or answer questions, a shorter questionnaire of 5 to 6 questions would be 
more realistic to administer.  Studies that examined action plans to educate on self-
maintenance of COPD primarily used the SGRQ to evaluate QOL (Ko et al., 2016; 
Trappenburg et al., 2011)  Development of such an instrument will require testing for 
validity and reliability.  A wide spread of BMI results possibly reflected on the low end 
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(13.9 Kg/m2), a lack of nutritional intake and at the high end (70.0 Kg/m2), the probable 
consequence of poor food choices or availability, along with inactivity due to poor 
endurance from breathlessness caused by COPD. The primary diagnosis of acute 
respiratory failure could reflect participants delay in seeking medical care for changes in 
their respiratory condition and in some cases is an indication of the severity of their 
condition and/or impact of comorbidities. 
The ALA modified Action Plan delivered for each participant was part of their 
overall discharge instructions.  Each participant still received the standard discharge 
instructions, to include review of action and side effects of their home medication list and 
teaching on any other comorbidities.  The $5.00 gift card given to each participant who 
completed the in hospital part of the study and when the 30 day follow-up was completed 
by phone, was acknowledged by many participants as an incentive to enroll and 
participate in the study.  Despite the gift card, partly given as an incentive and 
acknowledgement of respect for participants’ time, there were a large number of 
dropouts.  Consideration should be taken in providing follow-up education and evaluation 
of QOL done as part of a post hospital office visit instead of a phone call. 
Selection of a QOL questionnaire with fewer questions may be more useful in this 
critically ill patient population.  Presenting the outcomes of the qualitative and 
quantitative findings from this research will be communicated to administration, in order 
to gain approval for the action plan to be used as an approved institutional discharge 






Throughout the study it was noted that almost all the participants would ask to 
have the study commence right after they agreed and signed the consent.  Subsequently, 
most of the trained PCU nurses were not immediately available to administer the 
instructions from the action plan, except in one case.   This is due to patient priorities on 
this busy PCU.  One of the three trained nurses was available to deliver the COPD 
modified action plan and the PI completed the QOL questionnaire.  Overall, there was a 
lack of retention in 30 day follow up.  Despite the PI calling participants, at their 
requested time (sent on 14 day postcard with a date) and sometimes twice, to answer the 
follow up questions, they either did not answer the phone or a message was left or they 
did not want to complete the survey and QOL questionnaire.  One participant stated on 
the second call back, “I don’t feel well right now, please call back.”  In some case there 
was no answer and a message was left, with no return call from the participant or a 
recording was given that the phone was no longer in service.  During the 30 day follow-
up phone calls to participants, few comments were obtained.  Participants would simply 
answer the questions repeated from the WHOQOL-BREF and the additional 6 questions 
on satisfaction with the discharge education.  For this reason only 10 verbal responses 
were available for the question on satisfaction of the COPD instructions.  Selection of a 
QOL questionnaire with fewer questions may be more useful in this critically ill patient 
population.  Also, participants were sent hospital addressed stamped envelopes to return 
the completed calendars, from which only two calendars were returned.  Minimal 
compliance to completing the calendar from participants is likely due to their impaired 
condition from COPD and other coexisting conditions.  Adding more tasks for the 
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participants to do beyond self-assessing their respiratory symptoms was apparently not a 
reasonable expectation.  Due to the small sample size on follow-up and the specific 
patient population being those with COPD hospitalized on a PCU, there is limited 
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This feasibility study establishes the ground work toward implementation of the 
ALA modified COPD Action Plan to be used for discharge instructions teaching self-
management skills to patients with COPD in the acute care setting.   Based on findings 
from various studies reported in the literature on COPD action plans or education, there 
are inconsistencies in their use, with mostly no specific information given on the content 
of instructions, while some included pharmacological (steroids and antibiotics) and 
nonpharmacological (pursed lip breathing) self-treatment for worsening respiratory 
symptoms.  The literature has little evidence in examining the use of COPD action plans 
on patients in the acute care setting with high acuity, high risk populations, and those 
with comorbidities.  In addition, reports of findings from researchers revealed 
inconsistent results of improvement on QOL following implementation of self-
management instructions (Choi, Chung & Han, 2014).  Many of the studies were 
conducted on those in the outpatient setting or after discharge with stable COPD or 
patients with COPD but not having other major comorbidities such as cardiac disease, 
making this feasibility study unique and challenging (Labreque et al., 2011; Ko, et al., 
2016, Trappenburg et al., 2011).  The PCU participants were found to have ‘some high 
school’ education (35%), majority were single (56%) and those not employed were 
(84%).  City Data (2015) reports the population where this study was conducted, has the 
lowest income level in the state.  Therefore, the SEM used as the theoretical framework 
for this study provided a sound platform for developing this study and bringing to light 
the factors impacting this population with COPD. 
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The principle-based concept analysis of inflammation involving COPD 
manuscript and the integrative review of instruments measuring risk factors predicting 
hospital admission manuscript for patients with COPD created a closely linked scholarly 
look at COPD in its complexity and highlighted the areas in need of future research.  
Evaluation of QOL following administering discharge instructions needs to be 
included, with consideration of alternate follow-up contact such as meeting participants at 
office visits or clinic visits.  Future studies are needed to examine outcomes using a larger 
sample size, to include other hospital units and compare a different COPD action plan.  
Comparison of two different COPD action plans would be necessary to include in the 
study design ethically, because standard of care prior to this study did not include any 
written COPD action plan for patients.  Delivering a structured individualized action plan 
may help overcome stumbling blocks that includes, lack of specific written instructions to 
teach patients self-management of their COPD and a copy for the patient to take home. 
Lessons Learned and Next Steps 
The modified COPD Action Plan was well received by the findings from 
participants who completed the 30 day follow-up survey.  Participants reported no 
readmissions for AECOPD (or COPD) on follow-up.  No significant changes were found 
in comparison of the mean domain scores from the WHOQOL-BREF questionnaire.  
There were several limitations observed in this study, one being a large dropout of 34 
participants after discharge, indicating a lack of retention and thus, poor follow-up.  A 
shortfall in follow-up after discharge from the hospital was likely related to moderator 
variables, primarily severity of COPD (primary admitting diagnosis acute respiratory 
failure (10, 20%) and socioeconomic factors (City Data, 2013).  The other limitation was 
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participants requested the instructions from the action plan and QOL questionnaire be 
administered soon after they were enrolled.  Trained PCU nurses were most of the time 
not available to provide the action plan instructions.  Since the study was conducted on a 
PCU, the results are limited in generalizability to other patient populations. 
Lessons learned from this study is that the patient population with COPD 
receiving care on the PCU are critically ill and have little reserve, physically (dyspnea, 
weak) and psychologically (anxious, depressed) that could have impacted adherence to 
follow-up.   Participants were eager in general to receive education from the modified 
ALA COPD Action Plan and had little difficulty giving accurate teach-back of the zones 
and appropriate action to take.  Some participants asked for alternative resources if they 
could not get an appointment with their physician when they felt their respiratory 
symptoms worsening.  This was an opportunity to inform participants of alternative 
resources, for example to seek care from urgent care centers located near their homes.  
Even though there were limitations, this feasibility study contributes to evidence that 
providing education to patients with COPD in the in the acute care setting is beneficial. 
Improvements in follow-up included reduced ED visits for COPD and empowerment of 
patients gaining knowledge in identification of changes in respiratory symptoms, as 
evidenced by patient satisfaction scores. Benefits of implementing self-management 
COPD instructions in the acute care setting include patients making the connection of a 
change in their respiratory symptoms and the need for hospital care.  In some cases, 
family or friends were available to be included in the instructions was another benefit.  
This study gained support from nursing colleagues, who were eager to contribute by 
carrying out this research intervention.  The next step is to obtain funding to conduct a 
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larger randomized clinical trial with multiple hospital units to compare implementation of 
the modified ALA COPD Action Plan and another COPD action plan and include follow-
up with participants during scheduled office visits.  
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Table 1. Inclusion and Exclusion Criteria 
Inclusion   Exclusion  
  
Adults  18  years-­‐of-­‐age  and  older  
Discharged  to  self-­‐care,  home  (independently  or  with  
family/significant  other)  
Primary  or  secondary  diagnosis  of  exacerbation  of  COPD  
(ECOPD),  J44.1  International  Classification  of  Disease  
(ICD-­‐10)  (2011)    
Score  of  15  on  the  Glasgow  Coma  Scale  
Understand  and  speak  English  
Have  access  to  a  working  phone  
Have  an  address  to  receive  mail  
  
Patients  with  a  tracheostomy,  not  able  to  talk  or  
communicate  
Using  BiPAP  (noninvasive  bi-­‐level  positive  airway  




     
98  
  








Table 4. PCU Nurse Evaluation on COPD Action Plan 
1.   PCU nurses rate acceptability and ease of 
delivery of action plan: 
 
(3) High  _______    
(2)Moderate _______   
(1)Low________ 
 
2.   Fits in with discharge instructions 
normally given to patients, please rate: 
 
a.   Good, fits into routine of patient care (3) 
b.   Somewhat of an added burden to deliver to 
participant (2) 
c.   An imposition to daily nursing activities (1) 





        
a.   10 minutes 
b.   15 minutes 
c.   25 minutes 
 
4.   Do you see this teaching plan as a benefit 
for future patients with COPD? 
 
 
a.   Yes 
b.   No 




Table 5. Demographics Characteristics of Participants on PCU 
	  




Age in years (n = 50) 49 84     (64.5/9.5) 
 Descriptive Frequency/Percent 
Gender Female 26 (52%) Male 24 (48%) 
Race AA (African American or 
Black) 
W (White) 
18 (36%)     
 
32 (64%) 
Smoker  Yes 19 (39.6%) No 29 (60.4%) 
Home oxygen  Yes 19 (38%) No (62%) 
Body Mass Index (BMI) Kg/m2 Minimum 13.9  Maximum 70.0 (24.4/11.4) 





  5 (10%) 










  4 (8.2%) 




   8 (16.3%) 
   
Primary diagnosis 
International Classification of 
Diseases- 10th revision (ICD-10) 
Frequency Percent 
Acute respiratory failure J96.20 10  20% 
Acute exacerbation of COPD (AECOPD) 
J44.1 
  4    8% 
Healthcare-Associated Pneumonia 
(HCAP) J18.9 
  4    8% 
Acute and chronic respiratory failure 
J96.20 
  3    6% 
Acute on chronic respiratory failure 
J96.22 
  3    6% 
Exacerbation of COPD (ECOPD) J44.1   3    6% 
Secondary diagnosis   
COPD J44.9 19  38% 
Exacerbation of COPD (ECOPD) J44.1 13  26% 
Acute exacerbation of COPD (AECOPD) 
J44.1 
 
  7  14% 





Table 6. RE-AIM: Results to Determine Feasibility of Study 
RE-AIM Dimension Measurements Results/Comments 
Reach 
Feasibility to recruit predetermined goal 
sample size of PCU participants (n = 
50). 
-Initial recruitment (n =50) in hospital 
and total of 37 dropouts. 
 
Diagram 1.  
-Retention: 
(n = 13) completed in-hospital study 
 
-30 day follow up via phone calls (n = 
13), this attrition was attributed in part 
to the impaired condition of the 
participants from COPD, comorbidities, 
as well as socioeconomic factors. 
Effectiveness (measured by outcomes  
and perception of  benefit) 
Participants’ perceived benefits of the 
COPD Action Plan, on 30 day follow up 
















One trained PCU nurse completed a 
questionnaire of rated and perceived 
benefit of the discharge intervention for 
participants with COPD. 
-Based on qualitative comments from 













-Rated questions on satisfaction with 
discharge protocol by participants 
 
 
-Trained nurse. The COPD Action Plan  
1. Perceptions about Delivery of COPD 
Action Plan reflected an appreciation of 
knowledge gained, two responses, 
“Person to person is always good” and 
“No one (before) took the time to go 
over this with me. I appreciate it.”  
2.  Based on participants feeling better 
related to Improved Self-Management 
Skills with a participant stating, “Doing 
exceptionally well. Eating healthy and 
stopped smoking” and another “Great.”  
3. Consequences of Decline related to 
COPD, “When real hot out, slow deep 
breaths still don’t help.” 
 
Do you think the discharge COPD Action Plan 
taught you to better take care of your 
respiratory symptoms and when to seek help? 
(n = 13)  
Yes = 12 (92.3%) 
No =     1 (7.7%) 
 
Gave moderate rating for acceptability 
and ease in delivery of the action plan 
(need to accommodate level of 
comprehension for each patient).  
Adoption 
Individuals willing to implement 
discharge instructions (one setting) 
Rated responses and 30 day outcomes 
of health care utilization and QOL 
outcomes 
 
-QOL results determined no significant 





























Wilcoxon signed-ranks test of median 
QOL scores indicated no statistical 
significance among domains (score of 
differences between means in hospital 
and 30 day follow-up: 
Physical           +1.4 
Psychological  +4.8 
Social                -1.3 
Environment     -2.4 
Rate satisfaction with COPD Action 
Plan and delivery:  
High = 4 (30.8%) 
Moderate = 9 (69.2%) 
Low = 0 (0%) Health care utilization st 
hospital, 30 day follow-up: 
Number of Emergency Department 
Visits:  
12 (99%) no ED visits 
  1 (1%) ED visits for insulin reaction 
Number of Hospitalizations: 
12(99%) no hospitalizations 
  1(1%) hospitalized 2 days,    COPD 
Number of times called #911 since 
discharge: 
0 (100%) none  
Number of office visits: 
5(40%) no visits 
7(55%) scheduled visits 




















-Trained PCU nurse scores/ratings  
 
30 day follow-up calendar, 2 were 
returned completed with the following 
results: Participant (1): green was 
marked for good day = 93% (28 days 
out of 30 total days recorded), yellow 
marked for some problems breathing = 
7% (2 days out of 30) and 3% (2 days 
out of 32, nothing was recorded).  
Participant (2): green marked = 64% (18 
day out of 28 total days recorded), 
yellow marked = 36% (10 days out of 
28).   
 
 
Acceptance and ease of delivery of the 
action plan, rated moderate.  
Recommended each patient needs 
individualized instruction based on their 
knowledge level. “Fits in with discharge 
instructions normally given to patients” 
was given the highest rating ‘good’.  
Implementation 
Consistency in delivery (fidelity) of the 
COPD discharge procedure, feedback 
from participants, and the nurse’s 
recommendations.   
-Trained PCU nurse score supported 
implementation (based on one delivery 





-Observed consistency in delivery 
(fidelity) of the COPD discharge 
procedure 
Do you see this action plan as a benefit 
for future patients with COPD? 
Response was ‘Yes’.  
 
Length of time to deliver the action 
plan” was scored ‘15 minutes’. 
-Delivered COPD Action Plan per 
scripted dialog, as observed by PI. Only 
one trained PCU nurse was observed 
due to limitation in availability of 
nurses when participants enrolled to 
receive discharge instructions. 
Maintenance	  
Determined	  following	  completion	  of	  
this	  study,	  based	  on	  quantitative	  and	  
qualitative	  results	  of	  the	  COPD	  Action.	  
	  
Plan	  as	  an	  approved	  institutional	  
discharge	  procedure	  for	  patients	  with	  
COPD 
-­‐‑Results	  will	  be	  submitted	  to	  hospital	  
management. 
-­‐‑Clinical	  manager	  of	  PCU	  is	  planning	  
to	  use	  ALA	  COPD	  Action	  Plan	  on	  unit.	  
Use	  of	  the	  action	  plan	  institutional-­‐‑
wide	  will	  be	  determined.	  
	  
-­‐‑Obtain	  grant	  funding	  to	  compare	  
ALA	  COPD	  Action	  Plan	  and	  another	  
action	  plan	  in	  a	  randomized	  study	  




Table 7: 30 day Follow-up Phone Interview with Participates 
1.   Do you think the discharge COPD Action Plan taught you to better take care of 
your respiratory symptoms and when to seek help?  
Comments: 
Yes:          No: 
2.   Level of satisfaction with delivery of COPD Action Plan. 
 
 (3)Highly satisfied ___ (2) Moderate satisfaction ___ (1) Low satisfaction___  
 
3.   Number of ED visits: 
4.   Number of hospital admission in the last 30 day after discharge: 
5.   Number of office visits: scheduled           unscheduled 
6.   WHOQOL-BREF questionnaire administered:  
 
 
Table 8:  WHOQOL-BREF Domain Scores 
  
In hospital  
 
 
















































































-2.4 ±13.5 (-10.6, 5.8)      -.54 p = .59 






Figure 1. Postcard: Reminder of 30 Day Follow-Up Phone Call 
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Eligible	  Patients	  Approached	  
(n	  =	  68)	  	  
Agreed	  to	  Participate	  
(n	  =	  50)	  
Consented/Enrolled	  
(n=	  50)	  
Completed	  30	  day	  Post	  Discharge	  Interview	  	  
(n	  =	  13)	  
	  
Deaths	  (discovered	  on	  30	  day	  follow	  up)	  (n	  =2)	  	  
30	  Day	  Follow-­‐‑Up	  Dropouts	  (n	  =	  34)	  
	  	  
In	  Hospital	  Dropout	  (n	  =	  1)	  
Completed	  in	  Hospital	  Session	  
(n	  =	  49)	  
	  
(n	  =49)	  









This License Agreement is between American Lung Association (“ALA”), with its 
principal place of business at 1301 Pennsylvania Avenue NW, Suite 800, Washington, 
DC 20004 and Patricia Conley, RN MSN PCCN/Medical University of South 
Carolina/Research Medical Center (“You”).  You have asked for permission to use 
certain materials owned by ALA in your research project or study.  ALA grants your 
request subject to the following terms and conditions.  Your signature below indicates 
your agreement to comply with all the terms and conditions outlined below. 
 
Nature of Research Project or Study (the “Study”): 
Chronic Obstructive Pulmonary Disease (COPD) discharge action plan and perception of 
quality of life issues (QOL). The research study is part of my PhD program of study at 
the Medical University of South Carolina, School of Nursing. 
 
ALA Materials to be Use in the Study: 




American Lung Association. (2013). http://action.lung.org/site/DocServer/action-
management-plan.pdf. (Retrieved 8/30/2015). 
  
 
How the ALA Materials will be Used in the Study: 
The COPD Action Plan (ALA, 2013) will be used to in a research study as part of a 
discharge instruction guide presented verbally to each patient in the privacy of their 
hospital room. Also, each patient will be given a copy of the Action Plan to take home. 
The study and this ALA Action Plan will need to be approved for use by the Institutional 
Review Board at the Medical University of South Carolina and Research Medical Center. 
 
Time Period for Use of ALA Materials: 
The time period could be estimated 12 months (September, 2016 to September, 2017).  
 
Your Contact Information (Name, Title, Address, Phone and Email): 
Patricia Conley, PhD Student  
10017 E. 68th Terrace 
Raytown, Missouri 64133 




Appendix II:  
Institutional  Review  Board  for  Human  Research  (IRB)  
Office  of  Research  Integrity  (ORI)  
Medical  University  of  South  Carolina  
  
Harborview  Office  Tower  
19  Hagood  Ave.,  Suite  601,  MSC857  
Charleston,  SC    29425-­‐8570  
Federal  Wide  Assurance  #  1888  
APPROVAL:                          
This  is  to  certify  that  the  research  proposal  Pro00051799  entitled:  
Structured  COPD  Discharge  Education  and  Quality  of  Life:  A  Feasibility  Evaluation        
   Submitted  by:  Patricia  Conley  
   Department:  Medical  University  of  South  Carolina  
for  consideration  has  been  reviewed  by  IRB-­‐I  -­‐  Medical  University  of  South  Carolina  and  approved  with  
respect  to  the  study  of  human  subjects  as  adequately  protecting  the  rights  and  welfare  of  the  individuals  
involved,  employing  adequate  methods  of  securing  informed  consent  from  these  individuals  and  not  
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Appendix VI: Letter of Permission from Journal 
RE: Inclusion granted                                                                         November 17, 2016 
 
Dear Dr. Patricia Conley,  
  
Warm Greetings!  
 
Thank you for mail. Please proceed to include it. We apologize for the delay in response. 
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Jacobs Publishers 
9600 Great Hills 
Trail # 150w 
Austin, Texas 
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APPENDIX VII: Letter of Permission from the US WHOQOL Center 
Thank you for your interest in the World Health Organization Quality of Life — BREF 
US English Version Instruments.    
 
We distribute the WHOQOL-BREF U.S. English Version free of charge as electronic 
files. 
Any questions can be directed to: 
US WHOQOL Center 
Attn: Instrument Distribution Coordinator 
University of Washington, Department of Health Services 
Box 359455 
Seattle, Washington, USA 98195-9455 
Phone: (800) 291-2193 
Fax: (206) 616-3135 
Email: seaqol@u.washington.edu 
  
Although this information isn’t required, we would also appreciate a short description of 
how you plan to use the instrument. The information would be used to enhance the 
effectiveness of future instruments or revisions. 
Sincerely, 
Instrument Dissemination Coordinator, US WHOQOL Center 
Name (First, Last, Title): 




Medical University of South Carolina  
Mailing Address (Street, PO Box): 
10017 E. 68th Terrace  




Raytown, MO, 64133  






Feasibility Study of a COPD Discharge Protocol  
Sample Population: 
Hospitalized Critically Ill Patients  
Estimated Sample Size: 
30  
Estimated Study Start and Completion Dates: 
03/01/2015  
Brief Description of Project: 
The aim of the study in general is to evaluate the outcome of patients subjective score on 
gained knowledge, hospital readmission,emergency room visits, and calls to the doctor.In 
addition, the score of the patients self rating on quality of life (QOL) will be evaluated, 
hoping that the discharge instructions will improve their perception of having a better 
QOL. 
User Agreement for the WHOQOL-BREF Instrument 
Please read the following information carefully 
  
The UNIVERSITY OF WASHINGTON distributes the WHOQOL-BREF and its 
translations available in the following languages: U.S. English  
Therefore, User and UNIVERSITY OF WASHINGTON agree as follows:  
1.     UNIVERSITY OF WASHINGTON’s obligations 
UNIVERSITY OF WASHINGTON shall deliver the original WHOQOL-BREF and/or 
the translations requested by “User” subject to the following conditions: 
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§ The translations requested are available, and  
§ The present agreement is duly completed and signed by “User” 
2.     “User”’s obligations 
2.1   No modification 
“User” shall not modify, abridge, condense, adapt, recast or transform the WHOQOL-
BREF in any manner or form, including but not limited to any minor or significant 
change in wordings or organization in WHOQOL-BREF, without the prior written 
agreement of UNIVERSITY OF WASHINGTON, which agreement shall not be 
unreasonably withheld or delayed. 
2.2   No translation 
“User” shall not translate WHOQOL-BREF, without the prior written agreement of Dr. 
Donald Patrick. 
 
2.3   No reproduction 
“User” shall not reproduce the WHOQOL-BREF except for the limited purpose of 
generating sufficient copies for use in investigations stated hereunder and shall in no 
event distribute copies of the WHOQOL-BREF to third parties by sale, rental, lease, 
lending, or any other profit-making means. 
2.4. Publication 
   In case of publication of study results, “User” shall cite (1) “Bonomi AE, Patrick, DL., 
Bushnell, DM, Martin M (2000). Validation of the United States' version of the World 
Health Organization Quality of Life (WHOQOL) instrument. Journal of Clinical 
Epidemiology, 53(1), 13-17.” in reference section of the publication. (New publications 
may be added and older ones deleted). 
2.5  Provision of data 
All data, results and reports obtained by, or prepared in connection with the WHOQOL-
BREF shall remain the User’s property. However, UNIVERSITY OF WASHINGTON 
may request the User to share data, results and reports obtained through the use of the 
WHOQOL-BREF, which request User can accept or reject in its sole and unfettered 
discretion. UNIVERSITY OF WASHINGTON shall ensure the anonymisation of such 
data at three levels, by the removal of: any patient identification, any university or 
company identification and any therapy name. UNIVERSITY OF WASHINGTON will 
classify and reorganize such anonymous data and therefore, shall hold all intellectual 
property rights regarding these data when and if submitted to the data pool. 
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UNIVERSITY OF WASHINGTON may provide such reorganized data to third parties, 
for analysis in education, research, consulting, and specifically for the evaluation of 
cross-cultural equivalence and development of reference values for this WHOQOL-
BREF or for any other similar project. 
2.6   Payment 
2.6.1 Royalty fees (Authors) 
The use of the WHOQOL-BREF  is free of author’s royalty fees. 
2.6.2 Distribution fees (UNIVERSITY OF WASHINGTON) 
The use of the WHOQOL-BREF in studies is not subject to a distribution fee. 
 
2.6.3 Invoicement  
For the use of the WHOQOL-BREF, this completed user agreement shall suffice as 
invoicement.  
3. Copyright Infringement 
   The WHOQOL-BREF was developed by the World Health Organization at The 
University of Washington.  The World Health Organization holds copyright over the 
WHOQOL and all its present and future translations. Each new translation will be made 
available to third parties once it is available, through the World Health Organization, 
under the conditions described in the present document. 
If, at any time during the term of this agreement, « User » learns of any infringement by a 
third party of any Intellectual Property Rights in connection with the WHOQOL-BREF, 
« User » shall promptly notify UNIVERSITY OF WASHINGTON. UNIVERSITY OF 
WASHINGTON shall notify such infringement to Authors. Authors will decide to 
institute or not proceedings against the infringing party. 
   4. Confidentiality 
All and any information related to the WHOQOL-BREF including but not limited to the 
following: information concerning clinical investigations, creations, systems, materials, 
software, data and know-how, translations, improvements ideas, specifications, 
documents, records, notebooks, drawings, and any repositories or representation of such 
information, whether oral or in writing or software stored, are herein referred to as 
confidential information.  Likewise, any information provided by User to Authors 
relating to this Agreement, including information provided in this Agreement, shall be 
treated as confidential information. 
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In consideration of the disclosure of any such confidential information to the other, each 
party agrees to hold such confidential information in confidence and not divulge it, in 
whole or in part, to any third party except for the purpose specified in this agreement. 
5. Use of name 
It is agreed that UNIVERSITY OF WASHINGTON shall not disclose, whether by the 
public press or otherwise, the name of “User’ or institution”, to any third party to this 
agreement except to the copyright holder(s) of the WHOQOL-BREF.  
6. Liability 
6.1 In case of breach of contract 
In the event of total or partial breach by UNIVERSITY OF WASHINGTON of any of its 
obligations hereunder, UNIVERSITY OF WASHINGTON’s liability shall be limited to 
the direct loss or damage (excluding loss of profit and operating losses) suffered by 
“User” as a result of such breach and shall not include any other damages and particular 
consequential damages. 
6.2 In the scope of the use of the “Questionnaire” 
Under no circumstances may Authors or UNIVERSITY OF WASHINGTON be held 
liable for direct or consequential damage resulting from the use of the WHOQOL-
BREF. 
6.3 In the event of non-renewal of this Agreement 
In the event of non-renewal of this Agreement by UNIVERSITY OF WASHINGTON for 
any cause or failure by UNIVERSITY OF WASHINGTON to conclude a new agreement 
with “User” upon the expiry of this Agreement, UNIVERSITY OF WASHINGTON will 
have no liability for payment of any damages and/or indemnity to “User”. 
7. Term and termination  
This agreement shall be effective as the date of its signature by “User” and shall continue 
for a term of 10 (ten) years at least or until the term of the study above mentioned in 
SUMMARY OF THE STUDY. 
Either party may terminate this Agreement immediately upon providing written notice to 
the other party in the event of: (a) the other party’s unexcused failure to fulfil any of its 
material obligations under this Agreement or (b) upon the insolvency or bankruptcy of, or 
the filing of a petition in bankruptcy or similar arrangement by the other party.  User may 
terminate this Agreement for any reason upon 90 days written notice. 
Upon expiration or termination of this Agreement UNIVERSITY OF WASHINGTON 
may retain in its possession confidential information it acquired from WHOQOL-BREF 
while under contract. The obligations which by their terms survive termination, include, 
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without limitation, the applicable ownership, confidentiality and indemnification 
provisions of this Agreement, shall survive termination. 
8. Assignment 
This Agreement and any of the rights and obligations of “User” are personal to the 
“User” and cannot be assigned or transferred by “User” to any third party or by operation 
of law, except with the written consent of UNIVERSITY OF WASHINGTON notified to 
“User”. 
9. Separate Agreement 
   This Agreement holds for the above mentioned study only. The use of the WHOQOL-
BREF in any additional study of the “User” will require a separate agreement without 
additional fees, unless significant updates have been added to the user manual (new 
edition, etc.). 
10. Entire Agreement, Modification, Enforceability  
The entire agreement hereto is contained herein and this Agreement cancels and 
supersedes all prior agreements, oral or written, between the parties hereto with the 
respect to the subject matter hereto.  
This Agreement or any of its terms may not be changed or amended except by written 
document and the failure by either party hereto to enforce any or all of the provision(s) of 
this Agreement shall not be deemed a waiver or an amendment of the same and shall not 
prevent future enforcement thereof. 
If any one or more of the provisions or clauses of this Agreement are adjudged by a court 
to be invalid or unenforceable, this shall in no way prejudice or affect the binding nature 
of this Agreement as a whole, or the validity or enforceability of each/and every other 
provision of this Agreement. 
11. Governing law  
This Agreement shall be governed by and construed in accordance with the laws of the 
State of Washington.  Any disputes will be adjudicated first through the UNIVERSITY 
OF WASHINGTON and subsequently through courts in the State of Washington. 
Acceptance of Terms of User Agreement: 
 
I have read and agree to the terms listed in the user agreement above. 
 
You have completed the user permission form for the WHOQOL-BREF and are now free 
to download the instrument and scoring information at 
http://depts.washington.edu/yqol/WHOQOL-BREF 
 
Thank you for your interest in the WHOQOL-BREF!  
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